A Study of Influence of Duration of Untreated Psychosis on the Short Term Outcome in First Episode Schizophrenia in Institute of Mental Health, Madras Medical College, Chennai by Bharathi, K
i 
 
A STUDY OF INFLUENCE OF DURATION OF UNTREATED 
PSYCHOSIS ON THE SHORT TERM OUTCOME IN FIRST 
EPISODE SCHIZOPHRENIA IN INSTITUTE OF MENTAL 
HEALTH, MADRAS MEDICAL COLLEGE, CHENNAI 
 
Dissertation submitted to 
THE TAMIL NADU DR. M. G. R. MEDICAL UNIVERSITY 
in part fulfillment of the requirements for 
DOCTOR OF MEDICINE 
(BRANCH – XVIII) PSYCHIATRY  
EXAMINATIONS - APRIL 2015 
 
INSTITUTE OF MENTAL HEALTH, 
MADRAS MEDICAL COLLEGE, CHENNAI 10. 
 
April 2015 
ii 
 
CERTIFICATE 
This is to certify that this dissertation titled “A STUDY OF 
INFLUENCE OF DURATION OF UNTREATED PSYCHOSIS ON 
THE SHORT TERM OUTCOME IN FIRST EPISODE 
SCHIZOPHRENIA IN INSTITUTE OF MENTAL HEALTH” 
submitted by DR. K. BHARATHI, appearing for M.D (Psychiatry) 
degree examination in April 2015 is a original bonafide record of work 
done her under my guidance and supervision in part fulfillment of 
requirements of the Tamil Nadu Dr. M.G.R. Medical University, 
Chennai. I forward this to the Tamil Nadu Dr. M.G.R. Medical 
University, Chennai, Tamil Nadu, India.  
 
                                                               
 
 
The Director,                              The Dean, 
Institute of Mental Health,                        Madras Medical College, 
Chennai – 10. Chennai – 3. 
 
  
iii 
 
CERTIFICATE OF GUIDE 
This is to certify that the dissertation titled, “A STUDY OF 
INFLUENCE OF DURATION OF UNTREATED PSYCHOSIS ON 
THE SHORT TERM OUTCOME IN FIRST EPISODE 
SCHIZOPHRENIA IN INSTITUTE OF MENTAL HEALTH” is  
the original work of Dr. K. BHARATHI, done under my guidance 
submitted in partial fulfilment of the requirements for M.D. Branch – 
XVIII [Psychiatry] examination of The Tamilnadu Dr. M. G. R. Medical 
University, to be held in April 2015. 
 
 
 
 
   DR. W.J. ALEXANDARGNANADURAI, 
Associate Professor, 
Institute of Mental Health, 
Chennai 
 
 
 
  
iv 
 
DECLARATION 
I, Dr. K.BHARATHI, solemnly declare that this dissertation  
“A STUDY OF INFLUENCE OF DURATION OF UNTREATED 
PSYCHOSIS ON THE SHORT TERM OUTCOME IN FIRST 
EPISODE SCHIZOPHRENIA IN INSTITUTE OF MENTAL 
HEALTH, MADRAS MEDICAL COLLEGE, CHENNAI” was done 
by me at Institute of Mental Health, Madras Medical College, Chennai 
under my guidance and supervision of the Professor of Psychiatry, 
Madras Medical College, Chennai. 
This dissertation is submitted to the Tamil Nadu Dr.M.G.R. 
Medical University, Chennai – 32 in partial fulfilment of the University 
requirements for the award of the degree of M.D., Psychiatry. 
 
 
                                                                              DR. K. BHARATHI 
 
Place : Chennai 
Date : 29.09.2014 
                                                                                 
 
 
v 
 
ACKNOWLEDGEMENT 
I owe my thanks to THE DIRECTOR, Dr. R. JEYAPRAKASH.  
Institute of Mental Health, Chennai, for permitting me to utilize the 
facilities and clinical material for conducting this study.  
I must profusely thank my guide Associate Professor  
Dr. Dr. W.J.  ALEXANDAR GNANADURAI, M.D., for providing me 
with direction, guidance and encouragement throughout, without which 
this study would have been a futile attempt. 
I sincerely thank Dr. SHANTHI NAMBI, M.D., Head of the 
Department of Psychiatry, Institute of Child Health for devising this 
study, her constant encouragement and valuable guidance for this study.  
I am indebted to Dr. P. P. KANNAN, M.D., and  
Dr. SABITHA, M.D., DR.V.S.KRISHNAN Associate Professors of 
Psychiatry for motivation, expert advice and help rendered during the 
procedures and throughout this study. 
 I am extremely thankful to Assistant Professors,  
DR. SHANTI M.D, Dr. JEYA KRISHNAVENI, M.D., and  
Dr. SHANTHI MAHESHWARI, M.D., all the Assistant professors of 
Institute of Mental Health for their frequent encouragement and inputs.  
vi 
 
I wish to thank the paramedical and non medical staff of the 
Institute of Mental Health for their cooperation which enormously helped 
me in this study. 
I thank all those patients who consented to participate in the study, 
without   this study would not have been possible. 
The blessings and support of my sons, husband, need special 
mention. 
The blessings of Almighty without which this work would not have 
been possible is acknowledged with gratitude. 
 
 
  
vii 
 
 
viii 
 
 
                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
INDEX 
 
SERIAL 
NO 
 
TOPIC 
 
PAGE NO 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 5 
3 AIMS AND OBJECTIVES 38 
4 HYPOTHESIS 39 
5 MATERIALS AND METHODS  40 
6 RESULTS 48 
7 DISCUSSION 87 
8 SUMMARY AND CONCLUSIONS 94 
9 LIMITATIONS 97 
10 IMPLICATIONS 98 
11 FUTURE DIRECTIONS 99 
12 BIBLIOGRAPHY  
13 APPENDIX  
 
 
INFLUENCE OF DURATION OF UNTREATED PSYCHOSIS ON 
THE SHORT TERM OUTCOME IN FIRST EPISODE 
SCHIZOPHRENIA IN INSTITUTE OF MENTAL HEALTH, 
MADRAS MEDICAL COLLEGE, CHENNAI. 
ABSTRACT 
Objective: Previous studies have suggested that there may be an association 
between longer duration of untreated psychosis and poor outcome in first 
episode schizophrenia. These studies have been interpreted as providing 
evidence that untreated psychosis may constitute an active morbid process that 
is “toxic” to the brain. If untreated psychosis is neurotoxic, this would form a 
strong basis for early intervention in schizophrenia. 
Method: Fifty seven neuroleptic-naïve patients with ICD-10 schizophrenia 
were evaluated 12 weeks after their first inpatient hospitalization. We examined 
the relationship between untreated initial psychosis duration (measured from 
onset of first symptom as well as from first hospital admission) by conducting 
clinical interview, symptom severity by PANSS and CGI-S scale, premorbid 
social adjustment by PSA scale, and symptoms improvement after treatment by 
CGI-I scale. 
Results: Earlier age at illness onset was associated with longer duration of 
untreated prodromal psychotic symptoms. There were no significant gender 
differences in duration of untreated initial psychosis. There is significant 
association between untreated psychosis duration and premorbid functioning. 
After controlling for the effects of age at onset, the duration of untreated initial 
psychosis did not significantly impair subsequent symptom severity or 
remission of positive symptoms. 
Conclusions:  Significant negative correlation between duration of untreated 
psychosis and the age at first presentation and positive symptoms at the time of 
onset of psychosis.  Significant positive correlation between the duration of 
untreated psychosis and premorbid adjustment. This finding concludes that after 
controlling of all the confounding factors the duration of untreated psychosis is 
an independent predictor of outcome as stated in literature. So, early 
intervention is necessary. 
Key words: first-episode schizophrenia, premorbid adjustment, follow up, 
duration of untreated psychosis (DUP), clinical outcome. 
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INTRODUCTION 
Schizophrenia is arguably the most puzzling of psychiatric 
syndromes and one of its most debilitating. It is characterized by 
disordered cognition, including a gain of function in psychotic symptoms 
and loss of function in specific cognitive function, such as working and 
declarative memory. It is a chronic, disabling disorder.  Recent studies 
suggest interference at or even previous to the onset of the first onset will 
improve response to treatment with antipsychotics and outcome of the 
illness in long term. 
  Schizophrenia has received the greatest attention in terms of 
research. This is certainly because of the dramatic and devastating effects 
of the disorder can have on an individual quality of life and their 
prospects for employment, marriage, and parenthood. Schizophrenia 
affects about one in hundred individuals, usually beginning in late 
adolescent or early adulthood. Untreated, it runs a chronic, deteriorating 
course. In addition to the personal tragedy schizophrenia creates a 
substantial public health burden due to the cost of lifelong health care 
needs and lost productivity.   
There are effective interventions that can benefit individuals and 
help them to lead a more normal life. 
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Current research is directed towards establishing the causes of 
schizophrenia and investigating possibility of early interventions in those 
identified at high risk for the disorder or with prodromal symptoms. 
Research has consistently shown that longer duration of untreated 
psychosis is associated with poorer outcomes among persons with 
schizophrenia.   
Meta-analysis of studies suggested that delay in the initiation of 
treatment for psychosis and an increased level of duration of untreated 
psychosis is related with a poorer response to treatment and outcome in 
countries like India.  
Schizophrenia may be “biologically toxic” as suggested by Wyatt 
and that long-term morbidity due to psychosis may be prevented if 
patients were treated by anti-psychotics as early as possible. 
 Duration of Untreated Psychosis (DUP) has been reported as a 
self-determining marker of prognostic outcome; measurement error and 
variability in DUP in terms of heterogenecity have also been reported. 
Only moderately strong association was observed between DUP and 
Outcome, based on presented data 13% of variant are one third to one 
fourth who did not achieve remission. 
First episode of schizophrenia: 
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Many people experiencing their first episode will have no personal 
or family experience of mental ill health and some will lack insight that 
symptoms or a result of mental illness. As a result many patients will 
present in crisis and not directly complaining of psychotic symptoms. 
The range possible presentation is very wide. 
Commonly seen are  
1. Spouse or relative noticing withdrawn or bizarre behavior 
2. Failure to achieve educational potential with referral by school or 
student health services. 
3. Onset of personality change, social withdrawal, odd behavior. 
4. Presentation via criminal justice system. 
5. Presentation following deliberate self harm or suicidal attempt. 
6. First sign may be symptoms of other disorder (Depression, Mania, 
OCD, Panic disorder) 
First episode schizophrenia is often time diagnostic, may take 
month/year. It is usually necessary to admit people suspected of first 
schizophrenic episode in order to assess the extent of their 
psychopathology to provide, time for education and pharmacological and 
psychological treatment. 
Drake et al observed a significant relationship between the DUP 
and prognosis of short term illness:  earlier is the treatment, the better is 
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the improvement. This is due to the factors that impede the period 
between having a psychotic symptom and seeking treatment for it are the 
same ones that prevent effective treatment response. So, evaluating the 
reasons for delayed treatment is valuable. 
Symptoms of psychosis are alarming for the person and for his 
family and his friends.  Degree of symptoms interrupts education, work, 
and interpersonal relationships. If these symptoms are allowed to 
continue unchanged, they potentially deteriorate self confidence, 
friendships, family relation, and educational and vocational success.  
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REVIEW OF LITERATURE 
Emil Kraeplin (1856 to 1926) first delineated dementia praecox. 
Eugene Bleuler (1857 to 1959) coined the term Schizophrenia. He 
proposed the name denote a splitting of psychic functions which he 
considered to the basis of the illness. His description of the illness include 
4 primary symptoms were abnormal association, autistic behavior and 
thinking, abnormal affect and ambivalence.   
Bleuler considered the loss of association between thought process 
and thought, emotion, and behavior to be the hallmark of the illness.   
Hallucination, delusion, and social withdrawal diminished drive as 
secondary manifestation of the illness. He saw symptoms of 
schizophrenia in a continuum with normal behavior.  He was less 
concerned with the course of the illness. 
Kraeplin much more concerned with the understanding of the 
psychological mechanism underlying the disease process. He identified 
that schizophrenia rested on course and outcome. He also found that the 
recovery from schizophrenia was very rare, or even impossible, 
deteriorating and irreversible. He believed that dementia praecox was loss 
of the inner unity of the activities of intellect, emotion and volition. His 
appraisal of the outcome has been challenged by subsequent follow-up 
studies.  
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Kurt Schneider (1887 to 1967) in his classification of thought 
disorders attempted to make the diagnosis of schizophrenia more reliable 
by identifying a group of symptoms of schizophrenia that were the most 
characteristic of the illness.  His so called first rank symptoms included 
various forms of hallucinations, thought withdrawal, thought insertion, 
thought broadcasting, delusional perceptions and experiencing feelings 
and actions as made or influenced by external agents.  The presence of 
one of the symptoms, in the absence of intoxication, brain injury or clear 
affective illness, was taken as sufficient for making the diagnosis of 
schizophrenia. 
Psychotic symptoms (Positive symptoms): 
1. Hallucination 
2. Delusion 
Psychotic symptoms of schizophrenia define schizophrenia for the 
general public and for most physicians. They are the most obvious and 
dramatic symptoms of the illness, and for most people they are what is 
fascinating and frightening about schizophrenia.  IPSS studies suggest 
that more than 70% of people with schizophrenia have auditory 
hallucinations, and that percentage is probably higher in industrialized 
societies. The most common theme found in schizophrenia is persecutory; 
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it might be that the most common inciting event for the formation of a 
delusion is need to explain experience of auditory hallucination.   
The validity of the hallucinatory experiences seems self evident to 
most patients.  Potentially less distressing themes, like grandiose and 
religious content in delusions, are experienced by half or fewer people 
with schizophrenia.  It can be generally expected that delusion of 
persecution or religious content will have the most effect on patients 
behavior, although the response of each patients to each thought is of 
course dependent on that person and that situation.   
A review of investigation into the nature of the delusion finds that 
fact there does appear to be a root to delusion that can be understood 
outside the idiosyncratic experiences of the patient who experiences a 
“direct experience of meaning”. 
 Negatives symptoms: 
1. Restricted affect, 
2. Diminished emotional range, 
3. Poverty of speech, 
4. Curbing of interest, 
5. Diminished sense of purpose, 
6. Diminished social drive.  
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Severity of Negative symptoms predicts long term disability better 
than the severity of psychotic or disorganization symptoms. Positive and 
negative syndrome concept as formulated by T.J.Crow.  Most people with 
schizophrenia will experience depression and anxiety during their course 
of illness, depression has been variably reported as good prognostic 
feature and as a poor prognostic feature, it seems likely that depression in 
schizophrenia caries the same burdens it does for the other people and so 
adds to the burden of the illness, but the presence of significant 
depression might also be an indirect indicator of absence of the deficit 
syndrome and the long term disability associated with primary negative 
symptoms. 
Disorganisation:  
 Disorganisation syndrome has been part of the conception of the 
schizophrenia.  Since Kreaplin included hebephrenia in dementia prarcox 
but the behaviors experiences and associated pathology have been subject 
to less investigation than the psychotic and negative symptoms.  
Disorganisation symptoms certainly include, 
1. The formal thought disorder 
2. Bizarre and catatonic behavior 
3. Inappropriate affect 
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 Disorganisation can also include agitation and aggression including 
assuming postures, suggesting the person is preparing for violence, 
swearing, or broad movements of arms are the trunk as the patient 
ambulance.  Hygiene is frequently poor and as a group those with 
disorganized schizophrenia or more indifferent to routine activities of 
daily living or health care and healthcare maintenance, than are other 
patients with schizophrenia. 
Motor symptoms: 
 Motor behavior can include subtle repetitive hand movements or 
broad, complex and purposeless movements involve limbs and trunk, 
mannerisms, echopraxia, tics and symptoms of catatonia. 
Pathophysiology of Schizophrenia: 
  There is neither is single brain region nor a single neurochemical 
alteration, but several, which have been associated with schizophrenia.  
The prefrontal cortex, hippocampus, and thalamus are the regions most 
often implicated.  At cellular level reduced gray matter volumes, reduced 
size of neurons but without cell loss and reduced dentritic arborization 
and spines are the main observations seen in schizophrenia.  The cause 
remains unknown, but the implication of the finding is one of reduced 
connectivity in brain.  Neurochemical deficits in neurotransmitter system 
indicate abnormal synaptic communications between neurons. The 
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evidence suggests that deficit in the GABAnergic system in the 
neocortical regions and Glutamate system in the hippocampus exist, but it 
is premature to state this with certainty.  However, neurochemical 
abnormalities would certainly be expected impair neuronal 
communication. White matter may also contribute to connectivity deficits 
between brain regions implicated in schizophrenia.  Taken together, 
schizophrenia is disease of abnormal connectivity, one that may occur at 
cellular level, synaptic level or circuit level.  These findings have lead to 
speculation that frontal-temporal/parietal connectivity may be the final 
common pathway for the development of schizophrenia.  
 Researchers have focused on finding the single protein that would 
explain schizophrenia.  A shift in conceptual framework from searching 
for a specific protein defect (key protein targets dysregulated in brain 
substrates) in schizophrenia to searching for defects in neural networks 
underlying symptom domains may represent a plausible approach to 
investigating the pathophysiology of schizophrenia.   
 A number of other theories exist including those which postulate 
that schizophrenia is a neurodegenerative disorder, abnormality of 
information processing, meta-representation/theory of mind, working 
memory, neuronal migration or language. 
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Duration of untreated psychosis: 
Duration of untreated psychosis (DUP) is defined as delay in 
treatment with antipsychotics which was found to be associated with an 
unfavourable outcome of schizophrenia. 
Starting treatment as early in new onset of psychosis is a major 
concern worldwide. Many services are being recognized to provide and to 
support earlier detection and treatment of new onset of schizophrenia and 
other psychoses.  
 
Fig. 1: Duration of untreated psychosis is period between the onset 
of positive symptoms and starting of first treatment. End of first episode 
is at the end of first treatment. 
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Premorbid phase:  This is the first phase which is normal period for 
most of the patients, who eventually develop schizophrenia, when deficit 
be present they are usually slight, stable and symptomless. 
Prodromal Phase: It is the second phase which begins after puberty 
where symptoms develop with rising severity and downhill decline of 
global functioning. 
This period lasts two to five years in average. 
Pschotic phase: It is the third phase with profound psychotic 
symptoms in this period patient feels convinced that his hallucinations 
and delusions are true with the absence of insight in initial phase of the 
illness. 
Variations in the course and outcome of schizophrenia: 
 Systematic investigations into the course and outcome of 
schizophrenia where initiated by Kreaplin, who believed that the natural 
history of the disorder could provide a provisional validation of the 
disease concept, until final verification could be achieved by brain 
pathology.  Contrary to Kreaplin postulate of mental weakness is 
precisely the long term course of schizophrenia that reveals the greatest 
extent of variation across population and culture.  The course and 
outcome of schizophrenia exhibit striking heterogenicity and variability, 
both across and within population.  Patient with similar clinical and 
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diagnostic characteristic of baseline assessment develop a broad spectrum 
of outcome ranging from stable, clinical and social recovery after a single 
psychotic episode to chronic unremitting psychosis and severe 
impairment. 
 Long term follow up studies lend creditability to the conclusion 
that high proportion (30 %) of patients meeting the diagnostic criteria for 
schizophrenia may achieve relatively favorable outcome. 
Secular trends in outcome of schizophrenia: 
 A long term prospective on the course of schizophrenia over the 
successive generations is provided by a meta analysis of 320 outcome 
studies on schizophrenia or dementia praecox published between 1895 
and 1992 which comprise 51,800 subjects, overall 40% of the patients 
have been described as improved after an average length of follow up 5.6 
years.  There was a significant increase in the rate of improvement during 
1956 to 1985 compared to 1895 to 1955, clearly related to introduction of 
neuroleptic treatment but a secular trend toward better outcome with 
every successive decade has been present for much longer.  Coupled with 
virtual disappearance of the most malignant or catastrophic forms of 
schizophrenia which tendered to result in a profound defect state after a 
single psychotic episode or in death (lethal catatonia), these observation 
suggests that a transition to a less deteriorating course of schizophrenia 
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had been taking place prior to the advent of modern pharmacological 
treatment. 
 Concurrently with above trends in Europe and North America, 
reports from developing countries, usually based on small clinical 
samples pointed to a less disabling course and a high rate of recovery 
from schizophrenic psychosis in traditional societies Mauritus and Sri 
Lanka.  Good outcome cases included who would be expected to the poor 
outcome if Western prognostic criteria have been applied, however 
selection bias could not be excluded, as these studies were based on 
hospital admission only.   
In addition, clinical improvement could have been confounded 
with social adjustment many patients achieve in a comparatively 
undemanding environment. 
Many methods for an early recognition of psychosis risk were 
developed and their strength was experienced in the last two decades.  
They allow us to assess psychotic prodromal symptoms and pre-psychotic 
signs, and to foretell conversion to psychosis with different probabilities 
as suggested by Hafner and Maurer, 2006; Miller et al., 1999; and Yung 
in 2006. 
Commonly measured outcomes in schizophrenia are positive and 
negative symptom outcomes, cognitive function outcome, 
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neurobiological function outcomes, patient reported outcome, wider 
societal outcome, duration of untreated psychosis outcomes, and 
economic outcomes. 
The prolonged course of schizophrenia foregoing the first treatment 
contact has provoked the question whether the DUP or duration of 
untreated illness (DUI) is a predictor of a poor outcome. Results from 
studies on association with various indicators of a poor outcome – 
symptoms, cognitive deficits, social decline and frequency of relapses – 
are not completely reliable. The reason is not having a standardized study 
group composition and description and dimension of the onset of DUP 
and DUI. 
In 1996 McGlashan and Johannessen, presumed that deficits may 
be due to an attenuated synaptic plasticity of brain.  The disease becomes 
chronic, if the fundamental disease process of psychosis is not treated 
with antipsychotic medicines.  So, the antipsychotic treatment is having a 
benign effect on the underlying disease process or facilitates to conserve 
the plasticity of the brain. 
The association between DUP has been established by many 
studies, mostly defined by the first episode of persistent psychotic 
symptoms, and indicators of the course of the first episode or one year 
outcome using mainly clinical interviews.  Darke et al., in 2000 and 
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Emsley et al., in 2007 showed the major results were drastically positive 
correlations of prolonged DUP with a slower reduction of psychotic 
episodes and intensity of positive and negative symptoms and partly also 
with quality of life, numbers of readmissions and global functioning. This 
suggests that a late treatment of the first psychotic episode prolongs the 
remission of the episode.  Nevertheless, it should be remembered that a 
prolonged prodromal stage is associated with a prolonged duration of the 
first episode compared with acute psychotic episodes not preceded by a 
prodrome. 
Addington et al., in 2004 Loffler & Hafner, in 1999 have 
confirmed the results from short-term follow-up studies that a positive 
association between DUP and increased positive symptoms. But Haan et 
al. in 2003 found a considerable correlation only with negative symptoms 
over six years.  Bottlender et al. in 2003 found a significant correlation 
with both positive and negative symptoms over a period of 15 years.  
Harris et al. in 2005 by a naturalistic study with 318 first-episode patients 
followed up for 8 years after initial treatment, found a reasonable positive 
correlation between DUP and severity of positive symptoms and reduced 
social and occupational functioning, but no association between negative 
symptoms and DUP. 
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In 2005, Emsley et al., found no association between DUP and 
neurological irregularities as measured by the Neurological Evaluation 
Scale (NES) in 66 medication-naïve patients from an early-psychosis 
unit.  Available studies of patients treated with neuroleptic medications or 
without treatment information are not informative. 
The relationship between neuropsychological test and DUP 
outcomes are negative according to most of the studies because of the 
cognitive impairment runs a constant course more or less autonomous of 
the symptoms dimensions and in addition they are not clear constantly 
across the studies.  In 2007 Lappin et al., found a positive association 
between DUP and decreased verbal IQ, verbal working memory, and 
verbal learning, but information on management was not given.  
Robinson et al., in 1999 found no relationship between 
neuropsychological test and DUP.  
Study reviews and meta-analysis related to the outcome parameters 
purely indicating a tendency of consistency than simple studies.  In 2005, 
Perkins et al., by meta-analysis, based on their 43 publications, they 
concluded that a short DUP is disapprovingly related with global 
psychopathology, functional outcome and positive and negative 
symptoms, that this relationship seems to be independent of the effects of 
other factors, and that DUP does not seem to be related with symptom 
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dimension of neuro-cognitive functions.  He also stated that there is no 
relationship with abnormities of brain morphology, even though there is 
little evidence for this conclusion. 
In 2005, Marshall et al., carefully reviewed 26 studies published up 
to 2004 and found no association between DUP and first clinical 
valuation of psychopathology and social performance.  The significance 
of correlation is increased with a lengthening follow- up period from 
6 months to 12 or 24 months in almost all studies. The effect of DUP 
appeared strong even after calculating for premorbid adjustment in  
12 studies and this was affirmed by Sing in 2007.  From 10 Studies 
published between 1992 and 2000, it is stated that although there shows 
some evidence for an association between DUP and first effect to 
antipsychotic treatment, the strength of these findings and their 
independence form confounding variables are hitherto to be established, 
Norman and Malla (2001). 
Whether reducing DUP by timely treatment is able of warding off 
adverse consequences of the disorder is clinically a crucial question.  
Controlled intervention studies in beginning of illness and with 
adequately long follow-up periods are essential to ascertain whether it is 
the period of the dynamic disease process prior to the starting of an 
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efficient treatment or an adverse type of the disorder, pointed out by an 
insidious onset which actually predicts a poor outcome. 
Few studies of controlled trials, low-dose neuroleptic medication 
and/or cognitive-behavioral therapy of early positive symptoms with 
prodromal stage patients and at augmented or ultra-high psychosis risk of 
diverse definitions have constantly stated weak, but appreciably 
encouraging, treatment effects on symptoms and a decline in transitions 
to schizophrenia (French et al., in 2007; Lewis et al., in 2002; McGorry et 
al., in 2002).  The long-term illness course effects are not yet recognized.  
In summing up, at this period of time these studies can be seen as simply 
signifying that early interference administered in the first episode can 
have benign effects. 
As  observed by Marshall et al, The reason for this timely treatment 
is not just caring (to reduce the period of untreated distress) but a rising 
detection that the duration of untreated psychosis will have a major force 
both on direct progress rates and on long-standing outcomes and 
disability.  
Larsen et al and Birchwood et al noted that an independent effect 
of the DUP on outcome was attributed to a direct `neurotoxic' effect and 
to a `critical period' in personal development when people may miss out 
on vital social development and may obtain disabilities and patterns of 
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behavior with long-term cost.  The relationship between the DUP and 
outcome give some support for its use as a service-level prognostic 
measure in new onset schizophrenia.  
In 2006, Mcglashan observed that DUP is an appropriate measure 
only of the early recognition and function of early intervention services. 
The most important factor of relapse is the period of illness earlier to 
initiating antipsychotic medications as observed by the Northwick Park 
trial of First episode schizophrenia patients. 
It was Wyatt's decisive analysis (1991) of antipsychotics and the 
natural course of the schizophrenia that definitely established the 
significance of the extent of untreated psychosis as a predictive marker. 
 Short DUP was not only related with better ‘treatment 
receptiveness’ but also with better decline in negative symptoms, an 
appealing decision given that negative symptoms are decided less 
responsive to antipsychotics than positive symptoms.  
Clarke et al in 2006 a new study has even attempted to demonstrate 
the consequence of DUP on outcome, reporting that each component 
raise in DUP is associated with a 7.8 point augment in global functioning 
scores and a 1.9-point add to in positive symptom scores which assess 
illness course without calculating treatment.  Acute treatment studies of 
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the first episode of psychosis, mainly patients diagnosed with 
schizophrenia (May et al) shown parallel results. 
Craig TJ et al (2000) study of duration of untreated psychosis and 
24-month clinical outcome in a first admission patient series do not hold 
up the proposal of a psycho-toxic effect of extended exposure to 
untreated psychotic illness.  
WHO multi-national studies: 
 IPSS1968-International Pilot Study of Schizophrenia:  This found 
that higher proportion of patients in India, Colombia and Nigeria had 
better outcome on most dimensions than patients in developed countries 
at 2 and 5 years follow up assessment. 
WHO 10 countries study, in which epidemiological cohorts of first 
episode cases were uniformly assessed upon their first contact with 
community or hospital services, the better course and outcome in 
developing country areas could not be attributed to any particular clinical 
subtype of the disorder.   
The main outcome difference across the study areas was in the 
average length of symptom free remissions.  Analysis of the data revealed 
that the better overall pattern of course and the less disabling outcome in 
the study areas in developing countries were mainly attributable to a 
significantly greater percentage of patients remaining in remission of 
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symptoms over long periods after an acute psychotic episode rather than 
to milder or shorter psychotic episodes. 
DOSMED-study of Determinants of Outcome of Severe Mental 
Disorder, and ISOS-International Study of Schizophrenia (ISOS) were 
showed better outcome when the DUP is shorter in developed countries. 
Indian studies on duration of untreated psychosis and outcome:  
In 1981, multi centered trial conducted in India by ICMR (Indian 
council of medical research ), SOFACAS -Study of Factors Associated 
with Course And outcome in Schizophrenia,  in  lucknow, Vellore, and 
madras at the end of 2 and 5 years of  follow-up.  Outcome assessment 
was done which showed factors significantly associated with good overall 
outcome are; 
1. Short duration of illness 
2. Regular treatment compliance 
3. Patient not perceived unsafe by others 
4. Not avoiding patients by others 
5. Absence of financial difficulties 
6. Higher socioeconomic state 
7. Lack of hazardous behavior 
8. Rural setup and Higher religious activities 
9. Absence of schizoid traits. 
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Kulhara et al., 2000, stated that schematic psycho-educational 
services were associated with improved outcomes than routine out patient 
treatments. 
Study by N. Srinivasan tripathi et  al., in 2004, 75 patients with 
schizophrenia (never- treated) found in a community survey in Chennai, 
49 managed with antipsychotics were followed up continuously  for one 
year period and found that a good clinical, social and global outcome in 
about one third of patients ,and occupational outcome in half of the 
patients was observed. Patients with poor global outcome were not 
different from those with good outcome on demographic and clinical 
factors but for the presence of formal thought and delusional disorder. 
The fraction with good outcome in clinical, work and global measures 
decreases constantly with increasing DUP. This divergence was 
important for clinical and global outcomes after a DUP of 5 years. 
In 2006 Rathi Mahendran et al., found that Psychiatric co-
morbidity in first occurrence schizophrenia is correlated with worse 
prognosis in hospitalized patients of first occurrence schizophrenia by a 
longitudinal two year follow-up study.  This emphasis that the need for 
early finding and treatment of these comorbid conditions. 
Another Indian and Canadian study during 2010 by Srividya  
N. Iyer et al compared the various outcomes of first episode psychosis in 
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India with Canada. The results showed a major improvement over time in 
patients in India, than their counterparts in Canada for negative symptoms 
and functioning when age and marital status are held constant. But the 
positive symptoms and psychopathology in general did not show this 
time-by-place interaction. From this study we can come to a conclusion 
that the outcome initially in the course of schizophrenia can be influenced 
by socio-cultural context of the treatment. 
Chatterjee et al., 2010 observed that treatment in the initial part of 
schizophrenia predicted an improved outcome through higher literacy 
rate, minimal initial symptoms, family involvement, medication 
compliance and community involvement (Self  Help Groups) by their 
study involving 256 patients followed up for 4 years in rural part of Goa.  
A prospective trial of DUP and outcome of patients never- treated 
was done by Jagadish Thirthalli et al in 2011.  They found that in India 
the delay in getting treatment among psychotic patients is extensive. 
Longer DUP is related to poorer outcome in psychopathological and 
functional components. 
  Isaac and Padmavathi et al., in 2007 studied the factors causing 
good prognosis of schizophrenia in low- and middle-income countries 
(LAMI).  They observed a negative correlation between DUP and income 
in LAMI countries. The treatment cost is a barrier to care and financial 
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support for antipsychotic medications would augment the contact to 
treatment and outcome of psychotic disorder in LAMI countries. 
Factors shown to be associated with better prediction of psychosis in 
low- and middle-income countries: 
Well-known factors: 
 a reduced amount of emotion expressed 
 superior social support 
 Tolerating strange behavior by the family and society 
 Marital status 
Factors those are uncertain: 
 Low level of urbanization and industrialization  
 Early demise of those with worst outcome 
 Higher prevalence of acute schizophrenia 
Family studies: 
 Family studies clearly demonstrate that the risk of developing 
schizophrenia is increased in the relatives of patients.  It is higher in 
siblings and even higher in children of probands, reaching a life time risk 
10% or more.  This equates about the same morbidity risk, when a 
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population prevalence of the disorder of 1 % is assumed.  The lower risk 
among parents can be explained by the reduced reproductive fitness 
associated with schizophrenia.  Illness among parents is found mainly in 
those who become ill after having children and those who have a milder 
version of the illness, which might not satisfy the diagnostic criteria for 
disorder.  In addition it is possible that the de novo mutation events might 
contribute to this anomaly.  Among many studies, 2 studies  
showing significantly higher morbidity risk in relatives of patients 
compared with relatives of controls.  The morbidity risk in first degree 
relatives of schizophrenia varied widely from 1.4 to 6.5%, and in controls 
from 0 to 1%. 
Factors those need further studies: 
 Co morbid use of substance 
 Duration of untreated psychosis (DUP) 
 Interventions by medications 
Possibility of measuring DUP: 
Clinically it is hard to identify this time when a particular 
symptom or behavior makes the person form a non-psychosis to a 
psychosis domain as suggested by Moller in 2001. 
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The time between the first sign of psychotic illness and  
emergence of elaborate psychotic symptoms to duration between 
emergence of symptoms of psychosis to starting of treatment is different 
(Day et al, 1987). 
Few methodological and conceptual problems hamper the 
measuring of DUP retrospectively. So the measurement of DUP is 
frequently methodologically challenging one. DUP is often 
retrospectively defined, and the recall bias can be reduced by many 
sources such as medical records and detailed interviews with relatives.    
Determinants of DUP for an individual: 
When assessing the possibilities of shortening DUP and what the 
effects could be of  this possible change in the length of DUP, it is critical 
to know what factors predict and relate to either short or long DUP.   
Previous studies have shown that subjects who are living alone or 
homeless  and unemployed have longer DUP (Barnes et al. 2000, Chen et 
al. 2005, Oliveira et al. 2010), whereas the effects of acute onset and 
history of psychosis in the family seem to shorten DUP (Chen et al. in 
2005, Compton et al. in 2008). The effect of living with family and the 
involvement of family in help-seeking on the length of DUP are unclear 
(Morgan et al. 2006 and Compton et al 2008).  Compton et al., 2011 in 
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their study observed that living with family members and poverty was 
linked with longer DUP.  
Chong et al. (2005) evaluated the reasons for not seeking a 
psychiatrist and observed that besides the unknown reasons, there were 
two important reasons:  
1.  Not recognizing the presence of problem, and  
2.  The idea of problems attributed to supernatural or mystical 
reasons.  
The lack of knowing or finding other explanations for odd 
symptoms may not be that uncommon in Western societies either, 
although the finding was from an Eastern population. Studies by Burns, 
2012 and Cascio et al., 2012 found either gender or cannabis use is not 
related to the prolongation of DUP. 
 Determinants of DUP regarding the health-care system 
Determinants of DUP may be divided into two different types. One 
type of cause for delay in initiation of treatment is due to avoiding of 
treatment initiation as long as possible.  Another possible cause is defect 
in health care system that made the delay in initiation of treatment.  In 
most developed countries, psychosis is treated quickly and efficiently.  
Though, for a variety of reasons such as economic limitations, in 
developed countries not all requirements for treatment of psychotic 
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people may be met either and this is even worse in developing countries 
(Chiliza et al., in 2012). 
When does DUP end?: 
The end of the DUP is theoretically easy to date, but `the 
commencement of treatment' is in realism an equally compound 
construct. Does `untreated psychosis' stop when any form of treatment 
begins, when treatments with antipsychotic medications are started, when 
treatment at an optimal dose has been stick to for a sufficient duration, or 
when the disease itself abates?  Many trials do not formulate these 
differences understandable in their measure of DUP and treatment 
adequacy is not clearly defined in the scales used for those studies. In 
2005, Singh et al., observed that in clinical practice, some clinicians start 
antipsychotic treatment in the prodromal stages of the illness. How can 
DUP be measured in that type of cases? When starting the treatment, at 
the onset of psychosis with prominent mood symptoms should treatment 
with mood stabilizers or antidepressants without antipsychotics be 
considered for treatment and therefore the end of the DUP?  
Rating scales of DUP: 
Some rating scales were developed to record the commencement of 
psychosis retrospectively.   In 1993, Beiser et al., developed a checklist of 
behaviours outlining the evolution of initial appreciable symptoms, 
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appearance of psychosis and beginning of treatment-seeking. In 1992, 
Hafner et al., developed IRAOS-Interview for the Retrospective 
Assessment of the Onset of Schizophrenia.  IRAOS is a form of interview 
to evaluate symptoms, socio-demographic distinctiveness and 
psychological impairment in the time course of emerging psychosis.  
The Nottingham Onset Schedule (NOS) developed by Singh et al 
in 2005 is  short form of interview with leading questions. It is a rating 
scale to calculate the commencement in psychosis.  According to this 
scale the onset of psychosis is comprising of (1) a prodromal period of 
two parts, one is a period of `discomfort’ and another following period by 
`non-specific' symptoms; (2) emergence of psychotic symptoms; and (3) 
a upsurge of specific symptoms directing to a precise diagnosis. 
 The NOS gives a normalized and consistent ways of recording of 
initial changes in schizophrenia and finding fairly accurate time points for 
calculating several durations in budding psychosis. 
  This scale permits for many ways of to measure and to define delay 
in treatment by changing the beginning point of onset, including period of 
untreated illness (the time period between prodromal symptoms to 
treatment), period of untreated emergent psychosis (the time between first 
symptom of psychosis to treatment) and duration of untreated established 
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psychosis (the time between manifestation of fully fledged syndrome of 
psychosis to treatment). 
To assess the result of early treatment services is DUP a suitable 
marker? 
Craig et al, 2004 and Petersen et al, 2005 demonstrated in their 
trails that specialised early treatment services are more successful than 
routine care in promoting clinical outcomes and adherence of treatment.  
In 2002, McGorry et al, concluded that combined therapy of 
risperidone with psychotherapy decreased the risk of developing full-
fledged psychosis from their randomised controlled study in a high-risk 
prodromal population. 
A study project conducted by Melle et al., in 2004 and Friis and 
Johannessen et al., in 2005 in Denmark and Norway, compared outcomes 
in patients with first onset psychosis diagnosed by an early intervention 
team, with those seeking treatment in another area without early 
intervention facilities but with same healthcare services. Finally they 
found that patients entering the early treatment had decreased DUP of 
five weeks and better prognosis at three months. 
However a study conducted in London by Malla et al., in 2005 
compared previous to and subsequent to the implement of an early 
intervention programme in treating patients with schizophrenia but they 
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did not detect any fall in DUP following this initiative program.  But they 
argued that improving general practitioner skill in detecting and treating 
psychosis with novel antipsychotics results in milder illness. Therefore, 
the support for the usefulness of early case finding services in shortening 
DUP seems to be limited.  
DUP and recovery: 
The DUP estimate low recovery even after treatment for three 
months after confounding other markers of DUP and the severity of the 
disease at baseline.  
Recovery effect results from early case finding and early treatment 
which reduce DUP from six months to one month and outcome from 6 
years to one year.   
Thara et al., SCARF-Schizophrenia Research Foundation, Chennai 
based had conducted a study to know the impact of early intervention 
service within 6 months of emergence of psychosis to the outcome in 
2003. At the end of one year 80% of patients obtained full recovery and 
showed very few cognitive defects. 
These highlight the significance of implementing a well-organized 
community recognition and referral system, with timely delivery of 
efficient treatments, particularly for patients with first onset 
schizophrenia.  
32 
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Confounding variables associated with DUP:  
After correcting the effects of other factors DUP remained an 
important indicator of outcome. Functional outcome seemed to decrease 
considerably even with short treatment delays of more than a week, with 
more progressive worsening in functioning after very long DUP of more 
than a year. This outcome was related variably with pre-morbid 
modification of factors like female gender, presence of affective disorder, 
period of prodromal stage, and treatment with Early Psychosis Prevention 
and Intervention methods. 
Barnes et al., 2000 and Verdoux et al., 2001 in their studies 
confounding factors like age at onset, sex, premorbid condition, mode of 
onset and socio economic status are used to assess the Long DUP was 
associated with delayed treatment. Premorbid condition and mode of 
onset therefore denote built-in mechanism of psychotic illnesses 
interrelated to a shortened DUP, whatever the early intervention efforts.  
Singh et al., 2004 stated that even though acute onset is related with a 
short period of first episode, is not an independent indicator of outcome 
in psychosis when sex and premorbid functioning are confounded.  To 
summarize, DUP is an important indicator of outcome even after 
correcting the impact of these confounding factors.  
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Gender: 
Lobel et al 1992 and Larsen et al 1996 reported that males have a 
long duration of untreated psychosis than females but five other studies 
do not find any gender difference to be associated with outcome. 
Age at onset: 
Ho et al., ( 2000) in their follow up studies observed that longer 
DUP was appreciably associated to onset at younger age while many 
other studies failed to show any such difference.(Hans et al, Lobel et al, 
Larsen et al, Blake et al.) 
Symptoms at base line: 
Higher level of symptoms at presentation of illness like negative 
and positive symptoms have associated with prolonged duration lf DUP 
in many studies (Larsen et al, Browne et al, Malla et al, Blake  et al).  
Some studies showed the prolongation of DUP was associated only with 
the severity of negative symptoms but not with that of positive symptoms 
or general psychopathology severity.  Drake et al notified a relationship 
between prolonged DUP and higher positive but not negative symptoms 
at presentation, but others have found no relation to initial positive 
symptoms (Larsen et al, Malla et al). 
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Premorbid adjustment: 
In 1896, Kraepelin stated that a substandard psychosocial activity 
is a risk factor for developing schizophrenia. This is also supported by 
Gittelman and Klein in 1969, that is low intellectual and psychosocial 
performance before the onset of psychosis is associated with poorer short 
and long term outcome. 
Poor premorbid functioning is related to higher severityof overall 
symtomatology, social execution , negative symptom domain and early 
onset of schizhphrenia in 1998 by Malmberg. A.  
Poor premorbid adjustment is autonomously related with both DUP 
and worst outcome.  Poor adjustment delays access to health care, and 
consequently aggravating the risk of developing with a non-remitting 
course of psychosis. In 2008, P. Jeppesen et al, in their studies showed 
that poor pre-morbid adjustment is correlated autonomously with more 
negative symptoms and adverse social outcome.  
Response to treatment: 
Shorter DUP  was linked with a superior response to anti psychotic 
medications  as calculated by improvement in severity of symptoms, 
studied by Ucok.A and Polat A, in 2004. 
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Outcome in schizophrenia in fraction: 
Approximate guide to course and prognosis at 13 years follow up. 
1. 15 to 20 % first episode will not recur 
2. Few people will remain in an employment, 
3. 52 % are without psychotic symptoms in the last 2 years 
4. 52 % are without negative symptoms  
5. 55 % show good/fair social functioning 
Poor Prognostic factors: 
 Poor premorbid adjustment 
 Insidious onset 
 Onset in childhood or adolescent 
 Cognitive impairment 
 Enlarged ventricles 
 Hebephrenic schizophrenia 
 Family history of schizophrenia 
 Male sex 
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Good prognostic factors: 
 Female sex 
 Acute onset 
 Married persons 
 Marked mood disturbances, especially elation during initial 
presentation 
 Family history of affective disorder 
 Catatonic schizophrenia 
 Presence of precipitating stressors 
 Living in developing countries. 
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AIMS AND OBJECTIVES 
1.  To evaluate the influence of duration of untreated psychosis (DUP) 
on the short term outcome 
2.  To evaluate the influence of DUP with severity of the symptoms at 
beginning of the first treatment. 
3.  To assess the association of premorbid social adjustment on DUP. 
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NULL HYPOTHESIS 
1.  No association between improved and unimproved groups in terms 
of DUP. 
2.  No association between severity of symptoms at baseline and 
duration of untreated psychosis. 
3.  No association between modes of onset, socio demographic factors 
with DUP 
4.  No association between premorbid social adjustment and DUP 
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MATERIALS AND METHODS 
This study was done at the Institute of Mental Health, Chennai. 
SAMPLE: 
60 consecutive patients who were all admitted as in-patient in the 
institute of mental health, fulfilling the ICD 10 criteria for schizophrenia 
those were all diagnosed to have first episode and drug-naïve patients. 
INCLUSION CRITERIA: 
1. Age 18 - 45 years. 
2. Patients with schizophrenia fulfilling ICD-10 criteria for diagnosis. 
3. Drug naïve patients. 
4. First episode. 
EXCLUSION CRITERIA: 
1. Psychiatric disorders due to general medical condition 
2. Other primary psychiatric disorders 
3. Substance induced psychotic disorder 
4. Comorbid substance use 
5. History of head injury. 
6. Mental retardation and Epilepsy. 
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MATERIALS USED 
1. Semi structured proforma. 
2. Detailed Clinical interview. 
3. PANSS-Positive And Negative Syndrome Scale. 
4. Clinical Global Impression Scale (CGI-Severity, CGI-
Improvement). 
5. Premorbid Social Adjustment Scale (PSA Scale) 
Semi-structured Proforma: 
This was developed by including the socio demographic and 
clinical data, family history, subtypes of schizophrenia, DUP, mode of 
treatment, and duration of hospitalization. (Appendix I) 
Clinical interview  
Detailed clinical interview was done to diagnosis  schizophrenia 
which fulfills ICD-10 criteria. 
 Patients and their care givers were interviewed in detail about the 
history of onset of illness, initial behavioral changes, any type of initial 
treatment and prodromal symptoms by providing privacy to the patients. 
Determination of Duration of untreated psychosis: 
The determination of duration of untreated psychosis was done 
clinically by a detailed interview with the patient and their care givers. 
Prodromal symptoms were cautiously elicited and the beginning of 
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symptom of first-discomfort or change in behavior was obtained, it may 
be positive or negative symptom which decided the onset of psychosis.  
The evaluation of DUP incorporated the following, 
1. Positive symptoms like hallucinations, thought disorder, odd 
beliefs, and delusional disorder. 
2.  Negative symptoms like depression, lack of interest and 
motivation, loss of energy and loss of interest. 
3. Social decline like social withdrawal, poor interpersonal 
relationship, social evasion, and anhedonia. 
Outcome measured from clinical improvement after 12weeks of 
followup. 
Positive And Negative Syndrome Scale : 
It is a drug-sensitive tool which gives balanced illustration of  
Positive and Negative symptoms and measures their association to each 
other and to global psychopathology. This scale comprises of following 
subtype namely. 
 
1. Positive scale (seven items),  
2. Negative scale (seven items),  
3. General psychopathology scale (16 items) and  
4. Profile summary.  This includes  
 
 
43 
 
a) positive syndrome: sum of  P1 to P7,  
b) negative syndrome: sum of  N1 to N7, 
c) composite index: Positive minus negative,  
d) general psychopathology: sum of G1 to G16, and  
e) cluster scores of  
Anergia: a sum of N1, N2, G7, G10,  
Thought disturbances: a sum of  P2, P3, P5, G9,  
Activation: a sum of  P4, G4, G5,  
Paranoid: a sum of  P6, P7, G8, and 
Depression: a sum of  G1, G2, G3, G6. 
 In addition to interpretation of scale scores, percentile is also 
assessed by dividing raw score with total score.  
Interpretation of the percentile score: 
Above 95  - Symptom severity is Very high 
75 to 94  - High 
26 to 74  -  Average 
6 to 25  -  Low 
5 and below  - Very low 
 At the time admission PANSS scale assessed and the severity of 
the symptoms measured.  Follow up assessment done at 12 weeks. 
Clinical global impression scale: 
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 The CGI-S (Severity) is adapted from the CGI scale developed by 
Guy.W in 1976.  The severity of the symptoms assessed with this scale at 
the time of admission. This is observer- rated clinical experience scale 
which measures the severity of the illness by 7 point items.  CGI-S 
severity of illness score corresponds to PANSS score by the following 
points. 
CGI-S scale     PANSS score 
Mildly ill    -   58 
Moderately ill  -   75 
Markedly ill   -   95  
Severely ill    -   116 
CGI – Improvement scale (CGI-I) is also a 7 point item scale.  This 
is used to assess the treatment response of symptoms presented at the 
baseline of illness.  This rates from 1 (very much improved) to 7 (very 
much worse). 
The Premorbid Social Adjustment Scale: 
Premorbid period is assessed one year before the onset of the 
illness by interviewing the care-giver.  This scale is a 7 point-item scale 
modified from Cannon-Spoor scale (1992).  
Range from 0-good adjustment to 6-poor adjustment.  It is used to 
evaluate the premorbid functioning in four stages of life from early 
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childhood (0-11yrs), early adolescent (12-15 yrs), Late adolescent (16-18 
yrs) to adulthood (19 and above) with assessing in the five areas of  
1. Sociability and withdrawal, 
2. peer relationship,  
3. adaptation and interest in school, 
4. scholastic performance, 
5. social and sexual aspects (from Early adolescent to adulthood). 
Each item is separately scored for four stages from 0-6 and total 
score in calculated by summing up the scores obtained. The possible 
score is the highest score derived by summing up the maximum score for 
all items.  
The subscale score is calculated by dividing the total score by the 
possible score. The Overall score ranges from 0 – 1 which is finally 
derived by averaging all the subscale scores.  High overall score indicates 
poor premorbid functioning. 
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METHODS 
  
 Patients fulfilling the ICD-10 criteria for schizophrenia, admitted 
as in-patients in the Institute of Mental Health were evaluated. Those 
satisfying the inclusion and exclusion were taken in to the study. The 
diagnosis was obtained from case records and confirmed by  
2 psychiatrists; one of them is senior consultant.  
 Informed consent in the written form was obtained for participation 
in the study from patients as well as their care-givers. 
 The patients were given the semi-structured proforma, PANSS-
Positive and Negative Syndrome scale, CGI-S: Clinical Global 
Impression Severity scale and Premorbid Social Adjustment Scale –PSA 
at the time of admission. 
 Treatment in the ward was given by the psychiatrist in-charge of 
the ward depending upon the patient’s symptoms severity.  Treating 
psychiatrist was completely blind to the study sample.  
Follow-up assessment was done after a period of 12 weeks by 
administering PANSS and CGI-S.  All those who completed 12 weeks of 
follow-up were enquired from their care givers about compliance to 
medication. 
 The outcome was assessed using CGI-I (Improvement).  
The outcome variable was converted into dichotomous, unimproved  
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(4 or more than 4 which includes no change, minimally worse, much 
worse, and very much worse) and improved (less than 3 on CGI-I which 
includes minimally improved, much improved, very much improved). 
The data collected thus were tabulated and discussed with 
reference to aims and objectives of the study.  Statistical analysis was 
done using chi-square test, t-test, and correlation methods.  In measuring 
DUP more chance of right skew, hence after initial data analysis DUP 
was normalized by taking the log to base 10 to allow the use of 
parametric statistics (Pearson’s r, t tests) and these results were presented.  
Data was analyzed using SPSS 22.0. p<0.05 is considered as a 
statistically significant value. 
  Approval was obtained from the ethics committee, Madras 
Medical College, Chennai. 
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RESULTS 
 60 consecutive patients were screened, evaluated and entered in to 
the study. 
 At the end of 12 weeks follow up assessment was done. 58 patients 
reported along with their caregivers for follow-up assessment. Remaining 
3 patients were excluded, one patient was found to be HIV positive and 2 
patients were found missing from the ward. .At the end of 12 weeks 
follow-up assessment was done for all 57 patients reported along with 
their caregivers. 
Sample characteristics at admission (n=57) 
       Baseline sample included 57 patients among which 75.8% were 
men and 24.2% were women.  More than 90% of the patients were in low 
and middle socioeconomic status. 
 7% were uneducated, 15.8% up to primary school, 42.1% up to 
middle school, 21.1% up to secondary school, 8.8% were diploma, and 
5.3% were graduate.  31 (54.4%) were unmarried, 24 (42.1%) were 
married, 2 (3.5%) married and separated.  46 (80.7%) were in a joint 
family system, 11 (19.3%) in a nuclear family system.  29 (50.9%) were 
unemployed and 28 (49.1%) were employed among the sample. 
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TABLE 1 
MEAN OF THE WHOLE SAMPLE (N=57) 
Variables N Mean Std. Dev Min Max 
Age 57 31.82 6 19 42 
Duration of untreated 
psychosis 57 3.02 3 .25 10.00
Age of onset of Illness 57 28.46 6 17 38 
Duration of hospitalization
(days) 57 31.30 23 10 90 
Panss positive syndrome 57 18.67 8 9 34 
Negative syndrome. 57 19.74 8 7 39 
General psychopathology 57 34.21 10 15 68 
CGI-S Score 57 4.39 1 3 6 
CGI-I Score 57 3.26 1 2 5 
PMSA Score 57 .32 0 .0 .8 
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Age at onset of illness is 28.46 years; the mean duration of 
untreated psychosis was 3.02 years. 12 (21.1%) patient had a DUP 
between below one year, 18 (31.6%) patients had a DUP between 1 to 2 
year, 27 (47.4%) patients had a DUP more than two years. 
 Family history Schizophrenia was present in 10 patients (26.3% ).  
No family history of schizophrenia in 42 (73.7%). 
In unimproved group at 12 weeks the DUP mean value is 1.65. In 
improved group at 12 weeks mean value is 4.92.  The p value is less than 
0.01 which is statistically significant. 
 Duration of hospitalization in improved group mean value is 24.70 
days.In unimproved group mean value 28.9 both are statistically 
significant. (p=0.02) 
 
 
 
 
 
 
 
  
 
 
51 
 
TABLE NO 2 
CORRELATION OF DURATION OF UNTREATED  
PSYCHOSIS WITH OTHER VARIABLES 
 Duration of 
untreated psychosis 
Age of onset of Illness 
Pearson Correlation -.072 
P-Value .594 
N 57 
Panss positive syndrome 
Pearson Correlation -.324 
P-Value .014 
N 57 
Negative syndrome. 
Pearson Correlation .177 
P-Value .188 
N 57 
General psychopathology
Pearson Correlation -.037 
P-Value .786 
N 57 
 
 There is positive correlation between PANSS positive symptoms 
and DUP (p< 0.05).  There is no significant correlation between DUP and 
the age at onset of illness, negative syndrome, and general 
psychopathology. 
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TABLE NO 3 
GENDER WISE COMPARISON BETWEEN  
IMPROVED AND UNIMPROVED GROUPS 
 
 
 
Gender 
Outcome 
Improved Unimproved Total 
N % N % N % 
Male 25 75.8 18 75.0 43 75.4 
Female 8 24.2 6 25.0 14 24.6 
Total 33 100.0 24 100.0 57 100.0 
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Gender wise comparison between improved and unimproved groups 
 Among the improved group of patients 75.8% were males and 
24.2%were females. In the unimproved group 75% were males, 25% 
were females.  The difference was not statistically significant. 
                           
 
 
 
 
 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 0.004 0.948 
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TABLE NO 4 
COMPARISON OF GROUPS BY EDUCATION 
 
Education 
Outcome 
Improved Unimproved Total 
N % N % N % 
Uneducated 2 6.1 2 8.3 4 7.0
Primary 5 15.2 4 16.7 9 15.8
Middle 15 45.5 9 37.5 24 42.1
Secondary 7 21.2 5 20.8 12 21.1
Diploma 4 12.1 1 4.2 5 8.8
Degree 0 .0 3 12.5 3 5.3
Total 33 100.0 24 100.0 57 100.0
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Comparison of groups by education 
 
Chi-Square Test Value P-Value 
Fisher's Exact Test 5.079 0.417 
 
 Among improved group, 6.1% were uneducated, 15.2% were 
educated up to primary level, 45.5% up to middle level, 21.2% up to 
secondary level, 12.1% diploma level. 
 In the unimproved group, 8.3% uneducated, 16.7% primary level, 
37.5% middle school, 20.8% secondary level, diploma 4.2%, 12.5% 
degree level.  The difference was not statistically significant. 
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TABLE NO 5 
COMPARISON OF THE GROUPS BY EMPLOYMENT 
 
Occupation 
Outcome 
Improved Unimproved Total 
N % N % N % 
Unemployed 19 57.6 10 41.7 29 50.9
Employed 14 42.4 14 58.3 28 49.1
Total 33 100.0 24 100.0 57 100.0
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Comparison of the groups by employment 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 1.407 0.236 
 
  
In improved group, 42.4% were employed, and 57.6% were 
unemployed.   In unimproved group 58.3% were employed, 41.7% were 
employed.  This difference was not statistically significant. 
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TABLE NO 6 
COMPARISON OF THE GROUPS BY  
SOCIOECONOMIC STATUS 
 
Socio economic 
status 
Outcome 
Improved Unimproved Total 
N % N % N % 
Low 26 78.8 20 83.3 46 80.7 
Middle 6 18.2 4 16.7 10 17.5 
High 1 3.0 0 .0 1 1.8 
Total 33 100.0 24 100.0 57 100.0 
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Comparison of the groups by socioeconomic status 
 
Chi-Square Test Value P-Value 
Fisher's Exact Test 0.768 0.999 
 
  
In the improved group 78.8% were from low socioeconomic status, 
18.2% from middle socioeconomic status and 3% from high 
socioeconomic status. 
In unimproved group 80.7% from low socioeconomic status, 
17.5% from middle, and 1.8% from high socio economic status. The 
difference was not statistically significant due to this study done at 
Government institute, majority of patients are from the lower 
socioeconomic class. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
Pe
rc
en
ta
ge
Low
Socio econom
63
Middle
ical st
Hi
atus an
gh
d outcome
Impr
Unim
oved
proved
 
 
64 
 
TABLE NO 7 
COMPARISON OF THE GROUPS –TYPE OF FAMILY 
 
Type of family 
Clinical Outcome 
Improved Unimproved Total 
N % N % N % 
Joint 27 81.8 19 79.2 46 80.7 
Nuclear 6 18.2 5 20.8 11 19.3 
Total 33 100.0 24 100.0 57 100.0 
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Comparison of the groups –type of family 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 0.063 0.802 
 
 In the improved group 81.8% belong to joint family, 8.2% belong 
to nuclear family. In the unimproved group79.2% belong to joint family, 
while 19.3% belong to nuclear family. The p value is 0.802 and the 
difference was not statistically significant. 
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TABLE NO 8 
COMPARISON OF THE GROUPS WITH  
FAMILY HISTORY OF SCHIZOPHRENIA 
Family history of 
schizophrenia 
Improvement 
Improved Unimproved Total 
N % N % N % 
No 23 69.7 19 79.2 42 73.7 
Yes 10 30.3 5 20.8 15 26.3 
Total 33 100.0 24 100.0 57 100.0 
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Comparison of the groups with family history of schizophrenia 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 0.643 0.423 
 
Family history suggestive of schizophrenic illness was present in 
10 patients (30.3%) among improved group and in 5 patients (20.8%) in 
unimproved group. Since p value is 0.423, the correlation between the 
presence family history of psychosis and clinical outcome is statistically 
insignificant. 
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TABLE NO 9 
COMPARISON OF GROUPS BY  
SUBTYPES OF SCHIZOPHRENIA 
 
Types of 
schizophrenia 
Clinical Outcome 
Improved Unimproved Total 
N % N % N % 
Un differentiated 8 24.2 10 41.7 18 31.6
Paranoid 24 72.7 9 37.5 33 57.9
Hebephrenic 0 .0 2 8.3 2 3.5
Catatonic 1 3.0 3 12.5 4 7.0
Total 33 100.0 24 100.0 57 100.0
 
 
 
 
 
 
 
71 
 
Comparison of groups by subtypes of schizophrenia 
 
  Among the improved group of patients, 24 patients (72.7%) 
were paranoid type. 8 patients (24.2%) were undifferentiated type, and 
one patient (3%) was catatonic type. In the unimproved group, 10 patients 
(41.7%) undifferentiated type, 9 patients (37.5%) paranoid type,  
2 patients (8.3%) hebephrenic type, and 3 patients (12.5%) catatonic type.  
The p value is 0.02, the association is statistically significant. 
 
 
 
 
 
 
 
 
 
Chi-Square Test Value P-Value 
Fisher's Exact Test 8.330 0.020 
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TABLE NO 10 
COMPARISON OF GROUPS BY HOSPITALIZATION 
 
Duration of 
hospitalization 
(days) 
Clinical Outcome 
Improved Unimproved Total 
N % N % N % 
 ≤ 15 days 14 42.4 5 20.8 19 33.3
16 - 30 days 15 45.5 11 45.8 26 45.6
> 30 days 4 12.1 8 33.3 12 21.1
Total 33 100.0 24 100.0 57 100.0
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Comparison of groups by hospitalization 
 
 
 
 
 
 
 In the improved group, 14 patients (42.4%) were hospitalized for < 
15 days, 15 patients (45.5%) were hospitalized for 16-30 days, and 4 
patients (12.1%) for more than 30 days.  In unimproved group 5 patients 
(20.8%) were hospitalized for <15 days, 11 patients (45.8%) were 
hospitalized for16-30 days and 8 patients (33.3%) were hospitalized for 
more than a month.  Here, the p value is 0.086, thus showed no relation 
between these two groups in hospitalization for treatment by statistics. 
 
 
 
 
 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 4.913 0.086 
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TABLE NO 11 
COMPARISON OF THE GROUPS ON  
PREMORBID FUNCTIONING 
 
Variables Improvement N Mean Std. Deviation 
t-
Value  p-Value 
PSA Score 
Improved 33 .282 .2038
1.654 0.104 
Unimproved 24 .379 .2395
 
  
        In the improved group the premorbid social adjustment mean score 
was 0.282 and in the unimproved group mean score was 0.379. The p 
value was 0.104. The difference between the two groups was not 
statistically significant. 
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TABLE NO 12 
COMPARISON OF THE TWO GROUPS BY  
MODE OF TREATMENT 
 
 
 
 
  
Drugs Type used 
Improvement 
Improved Unimproved Total 
N % N % N % 
Typical 5 15.2 19 79.2 24 42.2
Typical & Atypical 28 84.8 5 20.8 33 57.8
Total 33 100.0 24 100.0 57 100.0
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Comparison of the two groups by mode of treatment 
 
 
 
 In the improved group 28 patients (84.8%) were treated with both 
typical and atypical antipsychotic drugs. 5 patients (15.2%) with typical 
drugs.  In unimproved groups 19 patients (79.2%) treated with typical 
drugs and only 5 patients (20.8%) were treated with typical as well as 
atypical antipsychotics. The p value is 0.0001 and hence the difference 
between two groups was statistically significant. 
 
 
 
 
 
 
 
 
Chi-Square Test Value P-Value 
Pearson Chi-Square 82.216 0.0001 
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TABLE NO 13 
CORRELATION OF DUP WITH IMPROVEMENT AT 12 WEEKS 
 
Duration of 
untreated 
psychosis 
Clinical Outcome 
Improved Unimproved Total 
N % N % N % 
Below 1 year 12 36.4 0 0.0 12 21.1 
1 - 2 years 16 48.5 2 8.3 18 31.6 
> 2 years 5 15.2 22 91.7 27 47.4 
Total 33 100.0 24 100.0 57 100.0 
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Correlation of DUP with improvement at 12 weeks 
 
Chi-Square Test Value P-Value 
Trend Chi-Square 28.284 <0.001 
 
 In improved group 12 patients (36.4%) showed less than 1 year of 
Duration of Untreated Psychosis.  In unimproved group 27 patients 
(47.4%) showed more than 2 years of DUP.  The p value is < 0.001 which 
is statistically significant. 
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TABLE NO 14 
CORRELATION BETWEEN PREMORBID  
FUNCTIONING AND DUP 
 
 
 
Poor premorbid functioning associated with longer DUP is 
statistically significant.  The p value is <0.005. This is statistically 
significant. 
 
 
 
 
 
 
 
 
 
 
 
Test values Duration of untreated psychosis 
PSA Score 
Pearson 
Correlation 0.366 
P-Value 0.005 
N 57 
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TABLE NO 15 
COMPARISON OF PREMORBID  
FUNCTIONING IN TWO GROUPS 
 
Variables Improvement N Mean 
Std. 
Deviati
on 
t-Value  P-
Value 
PSA Score 
Improved 33 0.282 0.2038 
1.654 0.104
Unimproved 24 0.379 0.2395 
 
 In improved group, the mean of PSA score was 0.282 and in 
unimproved group, mean of PSA is 0.239.  It is not significant. 
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Independent samples t-test to compare mean values between Improve 
and unimproved cases 
 
Variables Improvement N Mean 
Std. 
Deviatio
n 
t-Value P-Value 
Duration of untreated 
psychosis 
Improved 33 1.6461 1.06216 
5.631 <0.001 
Unimproved 24 4.9167 2.69729 
Age of onset of Illness 
Improved 33 29.67 5.972 
1.907 0.062 
Unimproved 24 26.79 5.090 
Duration of 
hospitalization (days) 
Improved 33 24.70 15.357 
2.419 0.021 
Unimproved 24 40.38 28.928 
Panss positive 
syndrome 
Improved 33 19.00 7.365 
0.382 0.704 
Unimproved 24 18.21 8.204 
Negative syndrome. 
Improved 33 18.09 6.984 
1.663 0.104 
Unimproved 24 22.00 9.860 
General 
psychopathology 
Improved 33 33.30 6.405 
0.729 0.472 
Unimproved 24 35.46 13.416 
CGI-S Score 
Improved 33 4.33 .595 
0.537 0.595 
Unimproved 24 4.46 1.021 
CGI-I Score 
Improved 33 2.58 .502 
13.418 <0.001 
Unimproved 24 4.21 .415 
PSA Score Improved 33 .282 .2038   
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 We compared the Duration of untreated psychosis with 
improvement of psychosis by confounding other variables, like gender, 
socioeconomic status, duration of hospitalization, symptoms at the initial 
stages, general psychopathology and premorbid functioning.  The DUP in 
our study showed a marked independent factor in predicting the clinical 
outcome statistically. The p value for DUP in this study is less  
than 0.001. 
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DISCUSSION 
 Studies state that a long duration of untreated psychosis associated 
with poor prognosis in schizophrenia.   
Socio demographic variables and DUP: 
 The mean duration of untreated psychosis for whole sample is 3.02 
years, which is longer than the DUP reported in studies done in Western 
countries, but mean DUP in this study is shorter when compared to some 
of the Indian studies (4 years in a study by Philip et al 11.64 years in a 
study by Padmavathi et al and more than 5 years by Tirupati et al).  
Among the whole sample 47.4% had a DUP greater than 2 years, which 
again confirms the finding that patient in developing countries come late 
to treatment (Isaac et al, Thara et al). 
 The role of socio demographic variables in determining the 
duration of untreated psychosis has given contrasting results across 
various studies.  Studies have shown that males have a longer DUP than 
females, but we could not establish any such difference in gender to be 
associated with DUP.  Numerous studies have not reported any relation of 
DUP with gender. 
 The finding of a significant positive correlation of DUP with the 
age at first presentation showed that the duration of untreated psychosis 
increases as the age at first presentation to treatment increases.  The result 
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being similar to the finding of Padmavathi et al that never treated patients 
were older in age and ill for a longer duration and were more 
symptomatic and severely disabled.  This finding is in contrary to other 
studies that have not found any association between age and DUP. 
          There is no significant correlation of duration of untreated 
psychosis with educational level, marital status and socioeconomic status 
at baseline assessment, a finding which is similar to most other studies.  
One study in India has reported that untreated patients were most often 
uneducated and divorced and such a finding is not found in our study.  In 
our study we found no correlation between DUP and employment, a 
finding contrary to the report of Morgan et al that unemployment has a 
less strong effect on duration of untreated psychosis. 
          Some of the Indian studies have reported that a longer duration of 
untreated illness in schizophrenic patients was due to the larger 
extended/joint family, which was able to compensate and cope with the 
dysfunctional member, concluding that such family system seemed to be 
crucial factor related to delay in treatment.  In our study, though 80.7% of 
the patients were in the joint family system, there was no significant 
correlation of family type with DUP.  In west London first episode study 
of schizophrenia most of the patients were living alone or homeless.  
However this study carried out in a government institute has its 
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limitations regarding demographic variables like educational status, 
socioeconomic status and employment.  
Clinical variables and DUP: 
 In our study there is significant association between 
undifferentiated schizophrenia of 10 patients (41.7%) with duration of 
untreated psychosis at baseline assessment.  Only few studies have 
studied the relation of diagnostic subtype with DUP and have not found 
any significant association. 
        In our study premorbid functioning is found to have a positive 
correlation with duration of untreated psychosis, showing that poor 
premorbid functioning is associated with a longer DUP than those with a 
better premorbid functioning, this finding is similar the studies done by 
Verdoux et al and Mella et al where they have reported that poor 
premorbid functioning is associated with long DUP and poor outcome.  
Some of the studies have not shown any association between DUP and 
premorbid functioning. 
        The correlation of DUP with symptom severity at baseline in this 
study has found a significant negative correlation with positive 
symptoms, has significant but not with negative syndrome and general 
psychopathology.  The finding is similar to studies that have found longer 
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DUP to be associated with higher levels of negative or deficit symptoms 
at first presentation (Perkins et al).   
 The negative correlation of DUP with positive symptom domain in 
the study implies that schizophrenic patients with positive symptoms seek 
treatment earlier and hence have a shorter duration of untreated 
psychosis.  As Drake et al reported that longer DUP was associated 
higher positive symptoms at presentation which is present in our study.  
Some of the studies do not find any such association between DUP and 
baseline symptoms (Loebel et al, & Hass et al). 
 Total number of patients at 12 weeks assessment is 57 patients, and 
the follow up rate is considerably lower when compared to most other 
studies, both Indian and studies done in Western countries.  The poor 
attrition rate could not be explained by any of the socio-demographic and 
clinical variables and the duration of untreated psychosis, finding similar 
to study done by Harris where they compared between those who 
completed follow up. 
    In the follow up assessment there is no significant difference 
between the improved and the unimproved group of patients on any of the 
socio-demographic variables such as education, socio-economic status, 
marital status, employment and family type.  This is contrary to the 
studies that have shown that being married has a good outcome. 
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 There is no significant association between the two groups by age, 
age at onset of illness which is contrary to the finding of Perkins et al that 
younger age at onset predicts a poor prognosis and is potential 
confounding factor of DUP and outcome. 
DUP and out come at 12 weeks: 
 There is a statistically significant difference between the improved 
and the unimproved groups on the duration of untreated psychosis, as the 
mean DUP for the improved groups is and unimproved group of patients.  
This finding is similar to other studies that shorter DUP is associated with 
good outcome and treatment response than those with a longer DUP.  In a 
study done by Philip et al, reported that patients with a short DUP have 
shown improvement at the end of 6 weeks following treatment.  There 
have been contrasting reports that DUP has an influence on the outcome 
in the short term but not on the long term.  Darke et al in his study 
concluded that DUP relationship to outcome is strongest in the initial 
months of psychosis and has implications for targeting early intervention. 
 The sub types of schizophrenia did not show any significant 
difference between the improved and unimproved groups though 
paranoid schizophrenia is the most common diagnosis in the sample. 
 In this study there is no difference among the two groups by family 
history suggestive of schizophrenia. 
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 In this study the duration of hospitalization between the two groups 
was not significant as more than 1 month hospitalization in unimproved 
group is 33.3% and in improved groups it is 12.1 %.  It is the same report 
observed by Hass et al that there is no significant difference in terms of 
duration of hospitalization between long and short DUP groups. 
Treatment response: 
 The mode of treatment between the two groups is statistically 
significant.  In improved group 28 patients (84.8 %) and in unimproved 
group (20.8%) were treated with both typical and atypical antipsychotics.  
This difference could not be explained by the fact that patients with short 
DUP would have had a better response to treatment as described by 
Perkins et al in his study.  This result has to be interpreted with caution as 
the type of drugs, dosage, and adequacy of dose was not included in our 
study.  Few studies differ as Barnes et al found that there was little 
evidence of any association between DUP and development of resistance 
to initial drug treatment. 
 In our study the premorbid social adjustment score is statistically 
significant between the improved and the unimproved groups, indicating 
that poor premorbid functioning is associated with poor improvement.  
This finding is similar to the reports of Verdoux et al that premorbid 
functioning is an important predictor of outcome. Again the premorbid 
social adjustment scale used in this study assesses premorbid functioning 
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in social and school activities, for which 45.5 % of sample is educated up 
to middle school and 6.1 % sample is uneducated in our study making it 
difficult to assess in these group of patients. 
Confounding factors, DUP and outcome: 
In order to find the relationship of confounding factors associated 
with DUP and outcome, an independent t-test was done, controlling for 
the confounding factors such as age at onset illness, severity of the 
symptoms domains of positive syndrome, negative syndrome, general 
psychopathology and premorbid functioning.  The correlation found that 
DUP is statistically significant after controlling for the confounding 
factors (p <0.001).  This result shows that duration of Untreated 
Psychosis is an independent predictor of outcome. 
 As premorbid functioning have shown that it is not statistically 
correlated with improvement at 12 weeks (p<0.104).  But premorbid 
functioning showed statistically significant correlation with DUP 
(p<0.005). 
 This finding is similar to studies that report premorbid functioning 
is not a strong predictor of outcome and the observed association between 
DUP and outcome was not explained by premorbid adjustment. 
 Thus in our study we found that DUP is an independent predictor 
of short term outcome of first episode schizophrenia.  
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SUMMARY AND CONCLUSION 
  
The aim of the study is to find the social and clinical determinants 
of untreated psychosis, the influence of duration of untreated psychosis 
on short term outcome and relationship of premorbid functioning on 
duration of untreated psychosis and outcome at 12 weeks in sample of 
first episode drug naïve schizophrenia patients diagnosed according to the 
ICD-10. Strict inclusion and exclusion criteria were used to get a 
homogenous sample.   
 60 patients were selected for the study of which 57 were assessed 
at baseline with socio demographic profile, duration of untreated 
psychosis, PANSS and CGI-Severity for psychopathology, PSA scale to 
assess premorbid functioning.  Details were obtained on admission; 
follow up assessment was done at 12 weeks. For treatment response 57 
patients followed up and were categorized in to improved and 
unimproved as per CGI-I scale.   
Reduction of PANSS symptoms, correlation of DUP with socio-
demographic, and symptoms at baseline were done.  Comparison between 
the improved and unimproved groups was done.  Results were analyzed 
using chi-square test, t-test, and Pearson’s correlation. 
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The study showed the following results 
1.  Significant positive correlation between duration of untreated 
psychosis and the age at first presentation. 
2.  Significant negative correlation between duration of untreated 
psychosis and positive symptoms at baseline. 
3.  Significant positive correlation between duration of untreated 
psychosis and premorbid functioning at base line. 
4.  Improved group patients had a better premorbid functioning than 
the unimproved group. 
5.  Improved group of patients had a short duration of untreated 
psychosis than the unimproved group. 
6.  Statistically significant difference between the improved and the 
unimproved groups by mode of treatment. 
7.  There is significant correlation of duration of untreated psychosis 
and premorbid functioning with improvement after confounding 
factors were controlled. 
8.  Thers is no significant difference between the improved and the 
unimproved groups in the negative symptoms at baseline. 
  The findings from this study suggest that a longer duration of 
untreated psychosis is associated with increased age at presentation, 
higher negative symptoms and poor premorbid functioning. The result 
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show that improved patients have a short duration of untreated psychosis 
and better premorbid functioning, the association is significant even after 
the confounding factors were controlled. 
 This finding concludes that duration of untreated psychosis is an 
independent predictor of outcome as stated in literature. So early 
intervention is necessary. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
97 
 
LIMITATIONS 
1. While finding the onset of psychosis before admission to the 
hospital may have the usual recall bias by the patient and care 
giver. 
2. As short term outcome was measured in this study the change in 
the symptoms after 12 weeks could be more a measure of treatment 
response, but not of social outcome and quality of life. 
3. Variables related to duration of untreated psychosis such as 
pathways to care, mode of onset, substance use were not included. 
4. Treatment details were not described in detail as it could have a 
significant influence on outcome. 
5. The researcher was not completely blind to the patients at time of 
follow up assessment as literature says that there is a likely chance 
for bias in assessment. 
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IMPLICATIONS 
Schizophrenia entails a progressive pathological course that is well 
established by the time the full blown psychopathology of psychosis 
appears.  The correlation between DUP and clinical outcome gives hope 
that early intervention services that are effective in reducing the duration 
of the initial psychotic event may augment the likelihood of recovery 
from a first episode of schizophrenia and possibly decrease collective 
morbidity.  Improving the symptoms of initial psychosis may benefit 
patients and their families, but it may also improve long-term prognosis 
by restricting progression of the disease and preserving a person’s ability 
to respond to antipsychotic treatment. 
In future, it will be essentially important to assess the effect of 
decline of the duration of untreated psychosis on initial negative symptom 
severity and negative symptom domain response to medical treatment.  
From a public health perspective, it is of chief importance to further study 
the relation between duration of untreated psychosis, premorbid 
characteristics, outcome in large sample sizes and in studies aimed at 
correlating the impact of early case finding and treatment of 
schizophrenia. 
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FUTURE DIRECTIONS 
Trials, that improve our knowledge of understanding of the 
possible mechanism for  correlation between DUP and clinical outcome 
should be done in the future which may give more critical information 
about the neuropathology of first episode of schizophrenia. The neuro-
developmental and possible progressive features of brain changes should 
be observed in first episode of schizophrenia in the future.  
The proof for clinical worsening after a long period of initially 
untreated first episode psychosis, manifested through the onset of 
secondary resistance to treatment with antipsychotics and progressive 
functional impairments, suggests that part of the clinical worsening 
characters of schizophrenia is mediated by a progressive patho-
physiological process.   
Studying schizophrenia over the lifespan including chronic, first 
episode, early and late onset, and prodromal patients and also subgroups 
of patients who respong and who do not respond  well to medication by 
finding the which brain changes can be detected early in the course of the 
illness an d how, this changes progress and whether or not there are 
difference in brain appearance between clinical subtypes of 
schizophrenia. 
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Relationship between gene and brain development and illness onset 
and progression need to be investigated.  Further studies that involve and 
combine multiple in vivo methodologies such as structural MRI, 
Mangnetization transfer ration (MTR), DTI (Diffusion Tensor Imaging) 
on one hand, and functional MRI, PET-Positron Emission Tomography 
and spectroscopy on other hand are already emerging.  This should 
replace single modality approaches within the next few years.  This 
change from single to multimodal imaging in the same patient will 
increase the understanding of the relationship between functional and 
structural brain abnormalities in schizophrenia and lay the foundation for 
linking such findings to signature cognitive impairments and 
susceptibility genes. There will be likely more studies of treatment 
efficacy and more attention paid to the critical period following first 
episode, where progressive changes in the brain are most evident. 
 At the end of this study we suggest that the future studies should 
include other factors such as recognition of illness, access to and 
availability of care for schizophrenia, social stigma, associated peri-natal 
complications and neurological soft signs. 
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APPENDIX 1 
Semi structured Proforma 
Name 
Age 
Sex 
Eduction-uneducted/primary/middle/high school/graduate 
Occupation-employed/un employed 
Socio economic status-low/middle/high 
Marital status-married/separated/divorced/widow/un married 
Type of family-nuclear/joint 
Family history-yes/no 
Age at onset- 
Diagnosis-paranoid/hebephrenic/catatonic/undifferentiated/simple 
Duration of untreated psychosis 
Duration of hospitalization 
Anti psychotic treatment- 
 
  
 
 
 
APPENDIX 2 
PANSS 
 
Positive Scale (Score 0 – 7) 
P1Delusions 
P2Conceptual disorganization 
P3Hallucinatory behavior 
P4Excitement 
P5Grandiosity 
P6Suspiciousness 
P7Hostility 
Scale total-49 
Negative Scale (Score 0 – 7) 
N1Blunted affect 
N2Emotional withdrawal 
N3Poor rapport 
N4Passive-apathetic social withdrawal 
N5Difficulty in abstract thinking 
N6Lack of spontaneity & flow of conversation 
N7Stereotyped thinking 
Scale total-49 
General Psychopathology Scale (Score 0 – 7) 
 
 
 
G1Somatic concern 
G2Anxiety 
G3Guilt feelings 
G4Tension 
G5Mannerisms & posturing 
G6Depression 
G7Motor retardation 
G8UncooperatJveness 
G9Unusual thought content 
G10Disorientation 
G11Poor attention 
G12Lack of judgment & insight 
G13Disturbance of volition 
G14Poor impulse control 
G15Preoccupation 
G16Active social avoidance 
Scale total-210 
 
  
 
 
 
APPENDIX - 3 
Clinical global impression scale 
1. Severity of illnes 
0 = Not assessed 4 = Moderately ill 
1 = Normal, not at all ill 5 = Markedly ill 
2 = Borderline mentally ill 6 = Severely ill 
3 = Mildly ill 7 = Among the most extremely ill patients 
2. Global improvement: Rate total improvement whether or not, in your 
judgement, it is due entirely to drug treatment. 
Compared to his condition at admission to the project, how much has he 
changed? 
0 = Not assessed 4 = No change 
1 = Very much improved 5 = Minimally worse 
2 = Much improved 6 = Much worse 
3 = Minimally improved 7 = Very much worse 
  
 
 
 
APPENDIX - 4 
Premorbid social adjustment scale 
 
Childhood (up through age 11) 
1. Sociability and withdrawal 
0 - Not withdrawn, actively and frequently seeks out social contacts 
2 - Mild withdrawal, enjoys socialization when involved, occasionally 
seeks opportunities to socialize 
4 - Moderately withdrawn, given to daydreaming and excessive fantasy, 
may passively allow self to be drawn into contact with others, but does not 
seek it 
6 - Unrelated to others, withdrawn and isolated, avoids contacts 
2. Peer relationships 
0 - Many friends (more than 5), close relationships (“best friends” or 
people you could confide in) with several 
1 - 2–5 friends 
2 - Close relationships with a few friends (1 or 2), casual 
friendships with others 
3 - Only casual friends 
4 - Deviant (unusual) friendship patterns: friendly with children younger or 
older only, or relatives only, or casual relationships only 
6 - Social isolate, no friends, not even superficial relationships 
 
 
 
3. Scholastic performance (as compared with all other students that 
age in the general population [i.e., a student doing very well in a special 
needs school would rate no higher than a 4]) 
0 - Excellent student (straight A’s – likely to attend a post-secondary 
institution) 
1 - A’s and B’s (likely to pursue post-secondary studies) 
2 - Good student (B’s – post-secondary) 
3 - Average student (B’s and C’s) 
4 - Fair student (C’s) 
5 - D’s – failing some classes 
6 - Failing all classes 
4. Adaptation to school 
0 - Good adaptation, enjoys school, no or rare discipline problems, 
has friends at school, likes most teachers 
1 - Likes school, few discipline problems 
2 - Fair adaptation, occasional discipline problems, not very interested in 
school, but no truancy or rare. Has friends in school, but does not often 
take part in extracurricular activities 
3 - Sometimes truant 
4 - Poor adaptation, dislikes school, frequent truancy, frequent discipline 
problem (may have been suspended) 
 
 
 
5 - Expelled from school 
6 - Refuses to have anything to do with school — delinquency or 
vandalism directed against school 
Early adolescence (12–15 years of age) 
1. Sociability and withdrawal 
0 - Not withdrawn 
2 - Mild withdrawal, enjoys socialization when involved, occasionally 
seeks opportunities to socialize 
4 - Moderately withdrawn, given to daydreaming and excessive fantasy, 
may passively allow self to be drawn into contact with others, but does not 
seek it 
6 - Unrelated to others, withdrawn and isolated, avoids contact 
2. Peer relationships 
0 - Many friends (more than 5), close relationships (“best friends” or 
people you could confide in) with several 
1 - 2–5 friends 
2 - Close relationships with a few friends (1 or 2), casual 
friendships with others 
3 - Only casual friends 
4 - Deviant (unusual) friendship patterns: friendly with children 
younger or older only, or relatives only, or casual relationships only 
 
 
 
6 - Social isolate, no friends, not even superficial relationships 
3. Scholastic performance (as compared with all other students that 
age in the general population [i.e., a student doing very well in a special 
needs school would rate no higher than a 4]) 
0 - Excellent student (straight A’s – likely to attend a post-secondary 
institution) 
1 - A’s and B’s (likely to pursue post-secondary studies) 
2 - Good student (B’s – post-secondary) 
3 - Average student (B’s and C’s) 
4 - Fair student (C’s) 
5 - D’s – failing some classes 
6 - Failing all classes 
4. Adaptation to school 
0 - Good adaptation, enjoys school, no or rare discipline problems, 
has friends at school, likes most teachers 
1 - Likes school, few discipline problems 
2 - Fair adaptation, occasional discipline problems, not very interested in 
school, but no truancy or rare. Has friends in school, but does not often 
take part in extracurricular activities 
3 - Sometimes truant 
4 - Poor adaptation, dislikes school, frequent truancy, frequent 
 
 
 
discipline problem (may have been suspended) 
5 - Expelled from school 
6 - Refuses to have anything to do with school — delinquency or 
vandalism directed against school 
5. Social-sexual aspects of life during early adolescence 
0 - Started dating, showed a “healthy interest” in the opposite sex, 
may have gone “steady,” may include some sexual activity 
1 - Attachment and interest in others, may be same-sex 
attachments, may be a member of a group, interested in the 
opposite sex, although may not have close, emotional 
relationship with someone of the opposite sex, “crushes” and flirtations 
2 - Consistent deep interest in same-sex attachments with restricted or no 
interest in the opposite sex 
3 - Casual same-sex attachments with inadequate attempts at relationships 
with the opposite sex. Casual contacts with both sexes 
4 - Casual contacts with the same sex, no interest in the opposite sex 
5 - A loner, no or rare contacts with either boys or girls 
6 - Antisocial, avoids and avoided by peers (differs from above in 
that an active avoidance of others rather than a passive 
withdrawal is implied) 
 
 
 
 
Late adolescence (16–18 years of age) 
1. Sociability and withdrawal 
0 - Not withdrawn 
2 - Mild withdrawal, enjoys socialization when involved, 
occasionally seeks opportunities to socialize 
4 - Moderately withdrawn, given to daydreaming and excessive 
fantasy, may passively allow self to be drawn into contact with 
others, but does not seek it 
6 - Unrelated to others, withdrawn and isolated, avoids contact 
2. Peer relationships 
0 - Many friends (more than 5), close relationships (“best friends” 
orpeople you could confide in) with several 
1 - 2–5 friends 
2 - Close relationships with a few friends (1 or 2), casual 
friendships with others 
3 - Only casual friends 
4 - Deviant (unusual) friendship patterns: friendly with children younger or 
older only, or relatives only, or casual relationships only  
6 - Social isolate, no friends, not even superficial relationships 
3. Scholastic performance (as compared with all other students that age 
in the general population [i.e., a student doing very well in a special 
needs school would rate no higher than a 4]) 
 
 
 
0 - Excellent student (straight A’s – likely to attend a post-secondary 
institution) 
1 - A’s and B’s (likely to pursue post-secondary studies) 
2 - Good student (B’s – post-secondary) 
3 - Average student (B’s and C’s) 
4 - Fair student (C’s) 
5 - D’s – failing some classes 
6 - Failing all classes 
4. Adaptation to school 
0 - Good adaptation, enjoys school, no or rare discipline problems, 
has friends at school, likes most teachers 
1 - Likes school, few discipline problems 
2 - Fair adaptation, occasional discipline problems, not very interested in 
school, but no truancy or rare. Has friends in school, but does not often 
take part in extracurricular activities 
3 - Sometimes truant 
4 - Poor adaptation, dislikes school, frequent truancy, frequent discipline 
problem (may have been suspended) 
5 - Expelled from school 
6 - Refuses to have anything to do with school — delinquency or 
vandalism directed against school 
 
 
 
5. Social-sexual aspects of life during early adolescence 
0 - Always showed a “healthy interest” in the opposite sex, dating, has 
gone “steady,” has engaged in some sexual activity (not necessarily 
intercourse) 
1 - Dated regularly. Had only one friend of the opposite sex with whom the 
subject went “steady” for a long time. (Includes sexual aspects of a 
relationship, although not necessarily intercourse; implies a twosome, 
pairing off into couples as distinguished from below) 
2 - Always mixed closely with boys and girls. (Involves membership in a 
crowd, interest in and attachment to others, no couples) 
3 - Consistent deep interest in same-sex attachments with restricted 
or no interest in the opposite sex 
4 - Casual same-sex attachments with inadequate attempts at adjustment to 
going out with the opposite sex. Casual contacts with both sexes 
5 - Casual contacts with the same sex, with a lack of interest in the 
opposite sex. Occasional contacts with the opposite sex 
6 - No desire to be with boys and girls, never went out with the opposite 
sex 
Adulthood (age 19 and above) 
1. Sociability and withdrawal 
0 - Not withdrawn, actively and frequently seeks out social contact 
 
 
 
2 - Mild withdrawal, enjoys socialization when involved, occasionally 
seeks opportunities to socialize 
4 - Moderately withdrawn, given to daydreaming and excessive fantasy, 
may passively allow self to be drawn into contact with others, but does not 
seek it 
6 - Unrelated to others, withdrawn and isolated, avoids contact 
2. Peer relationships 
0 - Many friends (more than 5), close relationships (“best friends” or 
people you could confide in) with several 
1 - 2–5 friends 
2 - Close relationships with a few friends (1 or 2), casual friendships 
with others 
3 - Only casual friends 
4 - Deviant (unusual) friendship patterns: friendly with children younger or 
older only, or relatives only, or casual relationships only 
6 - Social isolate, no friends, not even superficial relationships 
3. Aspects of adult social-sexual life 
A. Married presently or formerly 
0 - Married, only one marriage (or remarried as a result of death of 
spouse), living as a unit, adequate sexual relations 
1 - Currently married with a history of low sexual drive, periods of 
 
 
 
difficult sexual relations, or extramarital affair 
1 - Married more than one time, currently remarried. Adequate 
sexual relations during at least one marriage 
2 - Married, or divorced and remarried, with chronically inadequate 
sex life 
2 - Married and apparently permanently separated or divorced 
without remarriage, but maintained a home in one marriage for 
at least 3 years 
3 - Same as above, but divorce occurred over 3 years ago and while 
married, maintained a home for less than 3 years 
B. Never married, over 30 years of age 
2 - Has been engaged one or more times or has had a long-term 
relationship (at least 2 years) involving heterosexual or homosexual 
relations, or apparent evidence of a love affair with one person, but unable 
to achieve a long-term commitment such as marriage 
3 - Long-term heterosexual or homosexual relationship lasting over 
6 months, but less than 2 years 
4 - Brief or short-term dating experiences (heterosexual or homosexual) 
with one or more partners, but no long-lasting sexual experience with a 
single partner 
5 - Sexual and/or social relationships rare or infrequent 
 
 
 
6 - Minimal sexual or social interest in either men or women, isolated 
C. Never married, age 19–29 years 
0 - Has had at least one long-term love affair (minimum 6 months) 
or engagement, even though religious or other prohibitions or inhibitions 
may have prevented actual sexual union. May have lived together 
1 - Has dated actively, had several “boyfriends” or “girlfriends.” 
Some relationships have lasted a few months, but no long-term 
relationships. Relationships may have been serious but a long-term 
commitment such as marriage was not understood to be an eventuality 
3 - Brief or short-term dating experiences or affairs with one or more 
partners, but no long-lasting sexual experience with a single partner 
4 - Casual sexual or social relationships with persons of either sex with no 
deep emotional bonds 
5 - Sexual and/or social relationships rare or infrequent 
6 - Minimal sexual or social interest in either men or women, isolated 
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• Schizoprenia is a chronic disabling disorder for most affected individuals.vulnerablity to schizophrenia is 
releated to genetic and environmental factors that influence early brain development.About prognosis most 
recent studies suggest that early intervention can  improve outcome.Relationship of duration of untreated 
psychosis  and  outcome may indicate a neurodegenerative process and so have  important implication for 
understanding the pathophysiology  of schizophrenia.Understanding cause and consequence of untreated 
psychosis is important because duration of psychosis before intiation of treatment is potentially modifiable 
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Study Procedures 
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social outcome assessment for which we will be interviewing you with various questionnaires. You will be required to 
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Informed consent form 
Title of the study - Influence of duration of untreated  psychosis  on the short term  outcome of first 
episode schizophrenia 
 
 
Name of the participant: ____________________________________________ 
Name of the Principal/Co-Investigator: DR. K.BHARATHI 
Name of the Institution: IMH, MMC 
Name and address of the sponsor / agency(ies), if any: _____________________ 
 
 
I,________(name of participant), have read the information in this form (or it has been read to me). I was 
free to ask any questions and they have been answered. I am over 18 years of age and, exercising 
my free power of choice, hereby give my consent to be included as a participant in the study about the - 
Influence of duration of untreated psychosis on the short term  outcome of first episode schizophrenia  
 
(1) I have read and understood this consent form and the information provided to me. 
(2) I have had the consent document explained to me. 
(3) I have been explained about the nature of the study. 
(4)  I have been explained about my rights and responsibilities by the investigator. 
(5) I have informed the investigator of all the treatments I am taking or have taken in the past, including 
any native (alternative) treatments. 
(6) I am aware of the fact that I can opt out of the study at any time without having to give any reason and 
this will not affect my future treatment in the hospital. 
(7) I hereby give permission to the investigators to release the information obtained from me as result of 
participation in this study to the regulatory authorities, Government agencies, and ethics committee. I 
understand that they may inspect my original records. 
(8) I understand that my identity will be kept confidential if my data are publicly presented. 
(9) I have had my questions answered to my satisfaction. 
(10) I consent voluntarily to participate as a participant in the research study. 
      
I am aware, that if I have any questions during this study, I should contact the investigators. By signing 
this consent from, I attest that the information given in this document has been clearly explained to me 
and understood by me. I will be given a copy of this consent document. 
For adult participants 
Name and signature / thumb impression of the participant (or legal representative if participant 
Is incompetent): 
(Name) __________________________(Signature)___________________ Date: __________   
 
Name and signature of impartial witness (required for illiterate patients):  
(Name) __________________________ (Signature)___________________ Date:__________  
Address and contact number of the impartial witness: _________________________________  
 
Name and signature of the Investigator or his representative obtaining consent: 
(Name) __________________________ (Signature)___________________ (Date)__________ 
ஆராய்ச்சி ஒப்புதல் படிவம் 
ஆராய்ச்சியின் தைலப்பு- £¡fûN A°dL LôXRôURUôÏm U]£ûRÜ 
úSôVô°LÞdÏ úSô«u Øuú]t\m GqYôß CÚdÏm GuTûR Tt±V BnÜ  
பங்குெகாள்வrன் ெபயர்: 
ஆராய்ச்சி ெசய்பவrன் ெபயர்: மரு. Ï. TôW§ 
மருத்துவ நிைலயம்: அரசு மனநல காப்பகம், ெசன்ைன 
 
________________________எனும் நான் எனக்கு ெகாடுக்கப்பட்ட தகவல் தாளிைன 
படித்து புrந்துெகாண்ேடன். நான் 18 வயைத கடந்திருப்பதால் என்னுைடய சுய 
நிைனவுடனும் மற்றும் முழு சுதந்திரத்துடனும் இந்த ஆராய்ச்சியில் என்ைனச் 
ேசர்த்துக்ெகாள்ள சம்மதிக்கிேறன். 
நான் எனக்கு ெகாடுக்கப்பட்ட தகவல் தாளிைன படித்து புrந்துெகாண்ேடன். 
எனக்கு இந்த ஆராய்ச்சியின் ஒப்புதல் படிவம் விளக்கப்பட்டது. 
எனக்கு இந்த ஆராய்ச்சியின் ேநாக்கமும், விவரங்களும் விளக்கப்பட்டது. 
எனக்கு என்னுைடய உrைமகைள பற்றி விளக்கப்பட்டது. 
நான் இதுவைர எடுத்துக்ெகாண்ட அைணத்து மருத்துவ முைறகைளப் பற்றி 
ெதrவித்திருக்கிேறன். 
இந்த ஆராய்ச்சியில் இருந்து நான் எந்ேநரமும் பின் வாங்கலாம் என்பைதயும் 
அதனால் எந்த பாதிப்பும் எற்படாது என்பைதயும் நான் புrந்துெகாண்ேடன். 
என்ைன பற்றிய எந்த தகவல்களும் அைடயாளமும் ெவளியிடபட மாட்டாது 
என்பைத நான் புrந்துெகாண்ேடன். 
என்னுைடய முழு சுதந்திரத்துடனும் இந்த ஆராய்ச்சியில் என்ைனச் 
ேசர்த்துக்ெகாள்ள சம்மதிக்கிேறன். 
பங்ேகற்பாளர் ெபயர் மற்றும் ைகெயாப்பம்:___________&____________   
நாள்:____________ 
   பாதுகாவலர் ெபயர் மற்றும் ைகெயாப்பம்: ___________&____________  
நாள்:____________ 
ஆராய்ச்சியாளrன் ெபயர் மற்றும் ைகெயாப்பம்:________&_________ நாள்:_______ 
S.NO Age Sex eduction occuption
socioec
nomic 
status
type of 
family
marital 
status religion
   family 
history 
of 
schizopr
enia 
duration 
of 
untreate
d 
psychos
is   
Age of 
onset of 
Illness
type of 
schizopr
enia  
Drugs 
used
duration 
of 
hospitili
sation 
panss 
positive 
syndrom
e
negative 
syndrom
e.
genaral 
psychop
athology 
CGI-S CGI-I PMS A
1 32 f middle
unemplo
yed low nuclear married hindu no 2yr 30 paranoid
T.HPL,T.
RISPERI
DONE
1 
MONTH 17 10 27 5 3 O.5
2 37 m diploma
employe
d low joint single hindu no 2 years 35
un 
differetai
aed
T.HPL,T.
RISPERI
DONE
2 
MONTH 10 18 33 5 3 0.6
3 36 f middle
unemplo
yed low joint single hindu no 6 yrs 30
undiffere
ntied
t.HPL,T.
RISPERI
DONE
3 
MONTH 14 28 37 5 4 0.6
4 42 m primary
unemplo
yed low joint single hindu no 10yrs 32
un 
differenti
ed
t.HPL,T.o
lanzapin
e
3 
MONTH 11 23 32 5 4 0.4
5 37 m
secondar
y
unemplo
yed low nuclear single islam yes 4 month 36 paranoid
t.risperid
one 15 DAYS 34 23 45 5 2 0.3
6 35 m middle
employe
d middle nuclear married hindu no 3 yrs 32 paranoid
t.HPL,T.o
lanzapin
e
1 
MONTH 30 19 33 6 4 0.4
7 32 f primary
unemplo
yed low nuclear married hindu no 5yrs 27 paranoid
t.HPL,T.o
lanzapin
e
3 
MONTH
S 30 9 15 4 5 0.5
8 32 f
uneducat
ed
unemplo
yed low nuclear single no 2yrs 30 paranoid
T.HPL,T.
RISPERI
DONE 15 days 32 10 16 5 3 0.5
9 38 m
uneducat
ed
employe
d low nuclear married hin no 2 yrs 36
undiffere
ntied
typical,at
ypical I MONTH 12 23 32 4 2 0.3
10 23 f
secondar
y
unemplo
yed low nuclear married yes 6years 17
hebepren
ic
t.hpl,t.cpz
,t.risperid
one 20 days 9 32 54 5 5 0.6
11 38 f middle
unemplo
yed low nuclear married yes 3yrs 35 paranoid
t.hpl,t.cpz
,t.risperid
one 1 month 19 18 38 4 3 0.6
12 26 f primary
unemplo
yed low nuclear single no 1.5 yrs 24
un 
diffrentiat
ed
t.HPL,T.o
lanzapin
e 1month 9 27 32 4 3 0.5
13 33 m diploma
unemplo
yed low nuclear single no 3months 32 paranoid t.hpl 15 days 20 7 32 4 2 0.3
14 23 m middle
employe
d middle nuclear single yes 7month 22 paanoid
t.olanzepi
ne 20 days 20 22 32 4 2 0.3
15 40 m degree
unemplo
yed low joint married yes 5yrs 35 paranoid
T.HPL,T.
RISPERI
DONE
2.4 
months 15 19 30 3 4 0.6
16 26 m primary
employe
d low nuclear
married/s
eparted no 3yrs 23
undiffere
ntied
t.hpl,t.cpz
, 20 days 20 16 30 3 4 0.5
17 37 m
secondar
y
employe
d low nuclear married no 10yrs 27 paranoid
t.hpl,t.cpz
,t.risperid
one
2.5 
months 14 11 33 3 4 0.2
18 31 m middle
employe
d low nuclear married no 6months 30 paranoid
t.olanzepi
ne 10 days 21 20 35 4 2 0.7
19 19 m
secondar
y
employe
d middle nuclear single yes 1yr 18 paranoid
t.risperid
one 20 days 20 7 32 3 2 0.3
20 38 m middle
employe
d middle joint single no 6 months 37 catatonic
t.HPL,T.o
lanzapin
e
1 
MONTH 24 16 36 5 2 0.2
21 26 m middle
unemplo
yed low nuclear single yes 2.5 yrs 23
undiffree
ntiated
t.risperid
one 20 days 11 31 32 4 4 0.2
22 28 m primary
unemplo
yed low nuclear single no 2yrs 26 paranoid
t.risperid
one
1 
MONTH 14 21 30 4 3 0.1
23 25 m
secondar
y
employe
d middle nuclear single no 3yrs 22 catatonic
T.HPL,T.
RISPERI
DONE 2 month 18 39 68 6 5 0.6
24 42 m middle
employe
d low joint married no 2yrs 38
undiffere
ntied
t.risperid
one 10 days 9 29 42 5 3 0.2
25 28 m middle
unemplo
yed low nuclear single yes 2yrs 26 paranoid
t.risperid
one 10 days 25 16 35 5 2 0.2
26 26 m middle
employe
d middle nuclear married no 2yrs 24 paranoid
t.hpl,t.pz,
t.risperid
one
1 
MONTH 24 16 34 5 2 0.2
27 36 m middle
unemplo
yed low nuclear single no 6yrs 30 catatonic
thpl,t.ola
nzepine 3 months 14 7 36 4 4 0.8
28 28 m
secondar
y
employe
d low nuclear married yes 3yrs 25 paranoid t.hpl 10 days 15 27 38 4 3 0.1
29 27 m middle
employe
d low nuclear single no 3yrs 24 paranoid t.hpl 10 days 30 11 30 4 4 0.2
30 32 f middle
unemplo
yed low nuclear married hindu no 2yr 30 paranoid t.hpl 20 days 17 10 27 5 3 0.4
31 37 m diploma
employe
d middle joint single hindu no 2 years 35
un 
differetai
aed
T.HPL,T.
RISPERI
DONE
1 
MONTH 10 18 33 5 3 0.8
32 36 f middle
employe
d middle joint single hindu no 6 yrs 30
undiffere
ntied
T.HPL,T.
RISPERI
DONE
  
1MONTH 14 28 37 5 4 0.2
33 42 m diploma
employe
d low joint single hindu no 10yrs 32
un 
differenti
ed
t.risperid
one 10 days 11 23 32 5 4 0.8
34 37 m
secondar
y
unemplo
yed low nuclear single islam yes 4 month 36 paranoid
t.olanzepi
ne 15 days 34 23 45 5 2 0.1
35 35 m middle
employe
d low nuclear married hindu no 3 yrs 32 paranoid t hpl,t.cpz 20 days 30 19 33 6 4 0.1
36 32 f middle
unemplo
yed low nuclear married hindu yes 5yrs 27 paranoid t.hpl,t.cpz 20 days 30 9 16 3 3 0.1
37 32 f
uneducat
ed
employe
d low nuclear single no 2yrs 30 paranoid
t.risperid
one 14 days 30 10 16 3 4 0.1
38 38 m primary
employe
d low nuclear married hin no 2 yrs 36
undiffere
ntied
t.HPL,T.o
lanzapin
e 1 month 12 23 32 4 3 0.1
39 23 f
uneducat
ed
employe
d middle nuclear married yes 6years 17
hebepren
ic
thpl,t.ola
nzepine 2 month 9 32 54 5 5 0.5
40 38 f middle
unemplo
yed low nuclear married yes 3yrs 35 paranoid t.hpl,t.cpz 15 days 19 18 38 4 3 0.1
41 26 f middle
unemplo
yed low nuclear single no 1.5 yrs 24
un 
diffrentiat
ed
t.olanzepi
ne 10 days 9 27 32 4 3 0.3
42 33 m diploma
unemplo
yed middle nuclear single no 3months 32 paranoid
t.HPL,T.o
lanzapin
e 1month 20 7 32 4 2 0.3
43 23 m primary
unemplo
yed low nuclear single no 7month 22 paranoid
t.risperid
one 15 days 20 22 32 4 2 0.1
44 40 m degree
employe
d low nuclear married no 5yrs 35
undiffere
ntied
t.hpl,t.rIS
PERIDO
NE 1 month 15 19 29 3 4 0.6
45 26 m primary
employe
d low nuclear
married/s
ep no 3yrs 23
undiffere
ntied
t.risperid
one 15 days 9 30 24 5 4 0.1
46 37 m
secondar
y
employe
d low nuclear married yes 10yrs 27 catatonic
T.HPL,T.
RISPERI
DONE 1 month 14 30 24 4 4 0.6
47 31 m
secondar
y
employe
d low joint married no 6months 30 paranoid
thpl,t.ola
nzepine 2 month 21 20 35 4 2 0.1
48 2o m 12
unemplo
yed high nuclear single no 1yr 18 paranoid t.hpl 10 days 30 10 36 4 3 0.5
49 38 m middle
employe
d low nuclear single no 6 months 37 paranoid
t.olanzepi
ne 15 days 24 16 36 5 2 0.1
50 26 m degree
employe
d low nuclear single no 2.5 yrs 23
undiffree
ntiated
t.hpl,t.cpz
,t.risperid
one 1 month 11 31 32 4 4 0.2
51 28 m middle
unemplo
yed low nuclear single yes 2yrs 26 paranoid
t.olanzepi
ne 10 days 14 21 30 4 3 0
52 25 m
seconda
y
unemplo
yed low nuclear single no 3yrs 22
undiffere
ntied
t.risperid
one 15 days 18 39 68 6 5 0.1
53 40 m
secondar
y
unemplo
yed low joint married no 2yrs 38
undiffere
ntied
t.HPL,T.o
lanzapin
e
2 
MONTH 9 29 42 5 3 0.1
54 28 m middle
unemplo
yed low nuclear single no 2yrs 26 paranoid
t.HPL,T.o
lanzapin
e 1 month 30 11 42 5 4 0.1
55 26 m middle
unemplo
yed low nuclear married no 2yrs 24 paranoid
t.hpl,t.rIS
PERIDO
NE
 2 
months 18 7 26 4 3 0.2
56 36 m primary
employe
d low nuclear married no 3yrs 25 paranoid
t.olanzepi
ne 20 days 15 27 38 4 3 0.1
57 28 m middle
unemplo
yed low nuclear single no 3yrs 24 paranoid
t.HPL,T.o
lanzapin
e 20 days 30 11 30 4 4 0.1
